{"PATHWAY:2": "Platelet degranulation ", "PATHWAY:3": "Neutrophil degranulation", "PATHWAY:4": "Acetylation", "PATHWAY:5": "Paracetamol ADME", "PATHWAY:6": "Purine salvage", "PATHWAY:7": "Defective ADA disrupts (deoxy)adenosine deamination", "PATHWAY:8": "Ribavirin ADME", "PATHWAY:9": "Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)", "PATHWAY:10": "Adherens junctions interactions", "PATHWAY:11": "Myogenesis", "PATHWAY:12": "Post-translational protein phosphorylation", "PATHWAY:13": "Activation of BAD and translocation to mitochondria ", "PATHWAY:14": "PIP3 activates AKT signaling", "PATHWAY:15": "Downregulation of ERBB2:ERBB3 signaling", "PATHWAY:16": "AKT phosphorylates targets in the cytosol", "PATHWAY:17": "AKT phosphorylates targets in the nucleus", "PATHWAY:18": "Negative regulation of the PI3K/AKT network", "PATHWAY:19": "AKT-mediated inactivation of FOXO1A", "PATHWAY:20": "CD28 dependent PI3K/Akt signaling", "PATHWAY:21": "Co-inhibition by CTLA4", "PATHWAY:22": "G beta:gamma signalling through PI3Kgamma", "PATHWAY:23": "VEGFR2 mediated vascular permeability", "PATHWAY:24": "TP53 Regulates Metabolic Genes", "PATHWAY:25": "Constitutive Signaling by AKT1 E17K in Cancer", "PATHWAY:26": "Regulation of TP53 Degradation", "PATHWAY:27": "Regulation of TP53 Activity through Acetylation", "PATHWAY:28": "Regulation of TP53 Activity through Association with Co-factors", "PATHWAY:29": "Cyclin E associated events during G1/S transition ", "PATHWAY:30": "Cyclin A:Cdk2-associated events at S phase entry", "PATHWAY:31": "RAB GEFs exchange GTP for GDP on RABs", "PATHWAY:32": "RUNX2 regulates genes involved in cell migration", "PATHWAY:33": "Regulation of PTEN stability and activity", "PATHWAY:34": "FLT3 Signaling", "PATHWAY:35": "Regulation of localization of FOXO transcription factors", "PATHWAY:36": "Estrogen-dependent nuclear events downstream of ESR-membrane signaling", "PATHWAY:37": "KEAP1-NFE2L2 pathway", "PATHWAY:38": "SARS-CoV-2 targets host intracellular signalling and regulatory pathways", "PATHWAY:39": "PPARA activates gene expression", "PATHWAY:40": "Generic Transcription Pathway", "PATHWAY:41": "Transcriptional regulation of white adipocyte differentiation", "PATHWAY:42": "Nuclear Receptor transcription pathway", "PATHWAY:43": "Aspartate and asparagine metabolism", "PATHWAY:44": "DAP12 interactions", "PATHWAY:45": "Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol", "PATHWAY:46": "alpha-linolenic acid (ALA) metabolism", "PATHWAY:47": "Beta-oxidation of pristanoyl-CoA", "PATHWAY:48": "Beta-oxidation of very long chain fatty acids", "PATHWAY:49": "Peroxisomal protein import", "PATHWAY:50": "Regulation of actin dynamics for phagocytic cup formation", "PATHWAY:51": "VEGFA-VEGFR2 Pathway", "PATHWAY:52": "RHO GTPases Activate WASPs and WAVEs", "PATHWAY:53": "RAC1 GTPase cycle", "PATHWAY:54": "RAC2 GTPase cycle", "PATHWAY:55": "RAC3 GTPase cycle", "PATHWAY:56": "FCGR3A-mediated phagocytosis", "PATHWAY:57": "Glycolysis", "PATHWAY:58": "Phase 3 - rapid repolarisation", "PATHWAY:59": "Phase 2 - plateau phase", "PATHWAY:60": "TICAM1-dependent activation of IRF3/IRF7", "PATHWAY:61": "TRAF6 mediated IRF7 activation", "PATHWAY:62": "Activation of IRF3, IRF7 mediated by TBK1, IKK\u03b5 (IKBKE)", "PATHWAY:63": "NOTCH1 Intracellular Domain Regulates Transcription", "PATHWAY:64": "Constitutive Signaling by NOTCH1 PEST Domain Mutants", "PATHWAY:65": "Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants", "PATHWAY:66": "HSF1 activation", "PATHWAY:67": "Notch-HLH transcription pathway", "PATHWAY:68": "Cilium Assembly", "PATHWAY:69": "Transcriptional regulation by RUNX2", "PATHWAY:70": "RUNX2 regulates osteoblast differentiation", "PATHWAY:71": "Chaperone Mediated Autophagy", "PATHWAY:72": "Late endosomal microautophagy", "PATHWAY:73": "Aggrephagy", "PATHWAY:74": "Sulfide oxidation to sulfate", "PATHWAY:75": "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell", "PATHWAY:76": "Keratinization", "PATHWAY:77": "Beta defensins", "PATHWAY:78": "Defensins", "PATHWAY:79": "L1CAM interactions", "PATHWAY:80": "Polymerase switching on the C-strand of the telomere", "PATHWAY:81": "Telomere C-strand synthesis initiation", "PATHWAY:82": "Acyl chain remodelling of PC", "PATHWAY:83": "Acyl chain remodelling of PS", "PATHWAY:84": "Acyl chain remodelling of PE", "PATHWAY:85": "Acyl chain remodelling of PG", "PATHWAY:86": "Hydrolysis of LPC", "PATHWAY:87": "Synthesis of PA", "PATHWAY:88": "XBP1(S) activates chaperone genes", "PATHWAY:89": "Regulation of PTEN gene transcription", "PATHWAY:90": "Budding and maturation of HIV virion", "PATHWAY:91": "Uptake and function of anthrax toxins", "PATHWAY:92": "RIPK1-mediated regulated necrosis", "PATHWAY:93": "Regulation of necroptotic cell death", "PATHWAY:94": "Activation of BIM and translocation to mitochondria ", "PATHWAY:95": "BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members", "PATHWAY:96": "NRAGE signals death through JNK", "PATHWAY:97": "Signaling by BRAF and RAF1 fusions", "PATHWAY:98": "Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models", "PATHWAY:99": "RUNX3 regulates BCL2L11 (BIM) transcription", "PATHWAY:100": "FOXO-mediated transcription of cell death genes", "PATHWAY:101": "Mitochondrial protein import", "PATHWAY:102": "PINK1-PRKN Mediated Mitophagy", "PATHWAY:103": "Regulation of KIT signaling", "PATHWAY:104": "Negative regulation of FLT3", "PATHWAY:105": "Factors involved in megakaryocyte development and platelet production", "PATHWAY:106": "Sialic acid metabolism", "PATHWAY:107": "Defective GNE causes sialuria, NK and IBM2", "PATHWAY:108": "HCN channels", "PATHWAY:109": "G alpha (i) signalling events", "PATHWAY:110": "Relaxin receptors", "PATHWAY:111": "Beta-catenin phosphorylation cascade", "PATHWAY:112": "Disassembly of the destruction complex and recruitment of AXIN to the membrane", "PATHWAY:113": "Attachment of GPI anchor to uPAR", "PATHWAY:114": "G alpha (12/13) signalling events", "PATHWAY:115": "Ub-specific processing proteases", "PATHWAY:116": "Initial triggering of complement", "PATHWAY:117": "Activation of C3 and C5", "PATHWAY:118": "Regulation of Complement cascade", "PATHWAY:119": "Neddylation", "PATHWAY:120": "Antigen processing: Ubiquitination & Proteasome degradation", "PATHWAY:121": "Caspase activation via Death Receptors in the presence of ligand", "PATHWAY:122": "Toll Like Receptor 4 (TLR4) Cascade", "PATHWAY:123": "MyD88-independent TLR4 cascade ", "PATHWAY:124": "TRIF-mediated programmed cell death", "PATHWAY:125": "COPI-mediated anterograde transport", "PATHWAY:126": "COPI-dependent Golgi-to-ER retrograde traffic", "PATHWAY:127": "IKK complex recruitment mediated by RIP1", "PATHWAY:128": "TRAF6-mediated induction of TAK1 complex within TLR4 complex", "PATHWAY:129": "IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation", "PATHWAY:130": "POLB-Dependent Long Patch Base Excision Repair", "PATHWAY:131": "HDR through MMEJ (alt-NHEJ)", "PATHWAY:132": "DNA Damage Recognition in GG-NER", "PATHWAY:133": "Formation of Incision Complex in GG-NER", "PATHWAY:134": "Dual Incision in GG-NER", "PATHWAY:135": "Pre-NOTCH Transcription and Translation", "PATHWAY:136": "Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells", "PATHWAY:137": "NOTCH2 intracellular domain regulates transcription", "PATHWAY:138": "RUNX3 regulates NOTCH signaling", "PATHWAY:139": "NOTCH3 Intracellular Domain Regulates Transcription", "PATHWAY:140": "NOTCH4 Intracellular Domain Regulates Transcription", "PATHWAY:141": "Formation of paraxial mesoderm", "PATHWAY:142": "RAF/MAP kinase cascade", "PATHWAY:143": "MET activates RAS signaling", "PATHWAY:144": "Regulation of HSF1-mediated heat shock response", "PATHWAY:145": "Apoptotic cleavage of cell adhesion  proteins", "PATHWAY:146": "RUNX1 regulates expression of components of tight junctions", "PATHWAY:147": "Condensation of Prophase Chromosomes", "PATHWAY:148": "Condensation of Prometaphase Chromosomes", "PATHWAY:149": "Electric Transmission Across Gap Junctions", "PATHWAY:150": "Gap junction assembly", "PATHWAY:151": "RUNX2 regulates bone development", "PATHWAY:152": "Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal", "PATHWAY:153": "Separation of Sister Chromatids", "PATHWAY:154": "Resolution of Sister Chromatid Cohesion", "PATHWAY:155": "RHO GTPases Activate Formins", "PATHWAY:156": "Deposition of new CENPA-containing nucleosomes at the centromere", "PATHWAY:157": "Fanconi Anemia Pathway", "PATHWAY:158": "Mitotic Prometaphase", "PATHWAY:159": "EML4 and NUDC in mitotic spindle formation", "PATHWAY:160": "Macroautophagy", "PATHWAY:161": "Pyroptosis", "PATHWAY:162": "Endosomal Sorting Complex Required For Transport (ESCRT)", "PATHWAY:163": "HCMV Late Events", "PATHWAY:164": "Sealing of the nuclear envelope (NE) by ESCRT-III", "PATHWAY:165": "Translation of Replicase and Assembly of the Replication Transcription Complex", "PATHWAY:166": "Translation of Replicase and Assembly of the Replication Transcription Complex", "PATHWAY:167": "Antimicrobial peptides", "PATHWAY:168": "Purine catabolism", "PATHWAY:169": "O-linked glycosylation of mucins", "PATHWAY:170": "DAP12 signaling", "PATHWAY:171": "Inactivation, recovery and regulation of the phototransduction cascade", "PATHWAY:172": "RAS processing", "PATHWAY:173": "Potential therapeutics for SARS", "PATHWAY:174": "Nef mediated downregulation of MHC class I complex cell surface expression", "PATHWAY:175": "MHC class II antigen presentation", "PATHWAY:176": "Lysosome Vesicle Biogenesis", "PATHWAY:177": "Golgi Associated Vesicle Biogenesis", "PATHWAY:178": "Oxidative Stress Induced Senescence", "PATHWAY:179": "SUMOylation of DNA damage response and repair proteins", "PATHWAY:180": "SUMOylation of transcription cofactors", "PATHWAY:181": "SUMOylation of chromatin organization proteins", "PATHWAY:182": "SUMOylation of RNA binding proteins", "PATHWAY:183": "SUMOylation of DNA methylation proteins", "PATHWAY:184": "RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known", "PATHWAY:185": "Transcriptional Regulation by E2F6", "PATHWAY:186": "Stimuli-sensing channels", "PATHWAY:187": "Formation of TC-NER Pre-Incision Complex", "PATHWAY:188": "Transcription-Coupled Nucleotide Excision Repair (TC-NER)", "PATHWAY:189": "Dual incision in TC-NER", "PATHWAY:190": "Gap-filling DNA repair synthesis and ligation in TC-NER", "PATHWAY:191": "mRNA Splicing - Major Pathway", "PATHWAY:192": "SUMO is conjugated to E1 (UBA2:SAE1)", "PATHWAY:193": "SUMO is transferred from E1 to E2 (UBE2I, UBC9)", "PATHWAY:194": "Cytosolic tRNA aminoacylation", "PATHWAY:195": "Hyaluronan biosynthesis and export", "PATHWAY:196": "ABC-family proteins mediated transport", "PATHWAY:197": "Azathioprine ADME", "PATHWAY:198": "Mitochondrial ABC transporters", "PATHWAY:199": "Defective ABCB6 causes MCOPCB7", "PATHWAY:200": "Apoptotic execution phase", "PATHWAY:201": "CDH11 homotypic and heterotypic interactions", "PATHWAY:202": "ATP sensitive Potassium channels", "PATHWAY:203": "Ion homeostasis", "PATHWAY:204": "Defective ABCC9 causes CMD10, ATFB12 and Cantu syndrome", "PATHWAY:205": "SUMOylation of intracellular receptors", "PATHWAY:206": "VLDLR internalisation and degradation", "PATHWAY:207": "NR1H2 & NR1H3 regulate gene expression linked to lipogenesis", "PATHWAY:208": "NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux", "PATHWAY:209": "NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake ", "PATHWAY:210": "NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose", "PATHWAY:211": "NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis", "PATHWAY:212": "NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis ", "PATHWAY:213": "Formation of the cornified envelope", "PATHWAY:214": "Interleukin-37 signaling", "PATHWAY:215": "Interleukin-18 signaling", "PATHWAY:216": "Defective GALNT3 causes HFTC", "PATHWAY:217": "Defective C1GALT1C1 causes TNPS", "PATHWAY:218": "Defective GALNT12 causes CRCS1", "PATHWAY:219": "Dectin-2 family", "PATHWAY:220": "Termination of O-glycan biosynthesis", "PATHWAY:221": "snRNP Assembly", "PATHWAY:222": "Signaling by SCF-KIT", "PATHWAY:223": "Ion transport by P-type ATPases", "PATHWAY:224": "mRNA Splicing - Minor Pathway", "PATHWAY:225": "A tetrasaccharide linker sequence is required for GAG synthesis", "PATHWAY:226": "HS-GAG biosynthesis", "PATHWAY:227": "HS-GAG degradation", "PATHWAY:228": "Defective B4GALT7 causes EDS, progeroid type", "PATHWAY:229": "Defective B3GAT3 causes JDSSDHD", "PATHWAY:230": "Defective EXT2 causes exostoses 2", "PATHWAY:231": "Defective EXT1 causes exostoses 1, TRPS2 and CHDS", "PATHWAY:232": "Defective B3GALT6 causes EDSP2 and SEMDJL1", "PATHWAY:233": "Attachment and Entry", "PATHWAY:234": "Retinoid metabolism and transport", "PATHWAY:235": "Sensory processing of sound by inner hair cells of the cochlea", "PATHWAY:236": "Sensory processing of sound by outer hair cells of the cochlea", "PATHWAY:237": "NoRC negatively regulates rRNA expression", "PATHWAY:238": "rRNA modification in the nucleus and cytosol", "PATHWAY:239": "Major pathway of rRNA processing in the nucleolus and cytosol", "PATHWAY:240": "RNA Polymerase I Transcription Termination", "PATHWAY:241": "Xenobiotics", "PATHWAY:242": "Sphingolipid de novo biosynthesis", "PATHWAY:243": "Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK)", "PATHWAY:244": "Phase 4 - resting membrane potential", "PATHWAY:245": "Regulation of CDH11 mRNA translation by microRNAs", "PATHWAY:246": "Regulation of CDH11 function", "PATHWAY:247": "Dermatan sulfate biosynthesis", "PATHWAY:248": "mRNA Editing: C to U Conversion", "PATHWAY:249": "Formation of the Editosome", "PATHWAY:250": "EPHB-mediated forward signaling", "PATHWAY:251": "Clathrin-mediated endocytosis", "PATHWAY:252": "Amyloid fiber formation", "PATHWAY:253": "Peptide ligand-binding receptors", "PATHWAY:254": "Degradation of the extracellular matrix", "PATHWAY:255": "Cytosolic iron-sulfur cluster assembly", "PATHWAY:256": "Mitochondrial translation elongation", "PATHWAY:257": "CDC42 GTPase cycle", "PATHWAY:258": "RHOD GTPase cycle", "PATHWAY:259": "The retinoid cycle in cones (daylight vision)", "PATHWAY:260": "Retinoid cycle disease events", "PATHWAY:261": "Opsins", "PATHWAY:262": "Interferon gamma signaling", "PATHWAY:263": "DNA Damage/Telomere Stress Induced Senescence", "PATHWAY:264": "HDR through Single Strand Annealing (SSA)", "PATHWAY:265": "HDR through Homologous Recombination (HRR)", "PATHWAY:266": "Sensing of DNA Double Strand Breaks", "PATHWAY:267": "Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)", "PATHWAY:268": "Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks", "PATHWAY:269": "Resolution of D-loop Structures through Holliday Junction Intermediates", "PATHWAY:270": "Nonhomologous End-Joining (NHEJ)", "PATHWAY:271": "Homologous DNA Pairing and Strand Exchange", "PATHWAY:272": "Processing of DNA double-strand break ends", "PATHWAY:273": "Presynaptic phase of homologous DNA pairing and strand exchange", "PATHWAY:274": "Regulation of TP53 Activity through Phosphorylation", "PATHWAY:275": "G2/M DNA damage checkpoint", "PATHWAY:276": "Meiotic recombination", "PATHWAY:277": "Defective homologous recombination repair (HRR) due to BRCA1 loss of function", "PATHWAY:278": "Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function", "PATHWAY:279": "Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function", "PATHWAY:280": "Impaired BRCA2 binding to RAD51", "PATHWAY:281": "Impaired BRCA2 binding to PALB2", "PATHWAY:282": "Mitotic Telophase/Cytokinesis", "PATHWAY:283": "Kinesins", "PATHWAY:284": "COPII-mediated vesicle transport", "PATHWAY:285": "Cargo concentration in the ER", "PATHWAY:286": "Regulation of PLK1 Activity at G2/M Transition", "PATHWAY:287": "HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand", "PATHWAY:288": "Loss of Nlp from mitotic centrosomes", "PATHWAY:289": "Recruitment of mitotic centrosome proteins and complexes", "PATHWAY:290": "Loss of proteins required for interphase microtubule organization from the centrosome", "PATHWAY:291": "Recruitment of NuMA to mitotic centrosomes", "PATHWAY:292": "Anchoring of the basal body to the plasma membrane", "PATHWAY:293": "COPI-independent Golgi-to-ER retrograde traffic", "PATHWAY:294": "AURKA Activation by TPX2", "PATHWAY:295": "Effects of PIP2 hydrolysis", "PATHWAY:296": "Activation of RAS in B cells", "PATHWAY:297": "FCERI mediated NF-kB activation", "PATHWAY:298": "Integrin signaling", "PATHWAY:299": "Rap1 signalling", "PATHWAY:300": "Retrograde neurotrophin signalling", "PATHWAY:301": "Respiratory electron transport", "PATHWAY:302": "Cytoprotection by HMOX1", "PATHWAY:303": "TNFR1-induced proapoptotic signaling", "PATHWAY:304": "Regulation of TNFR1 signaling", "PATHWAY:305": "TNFR1-induced NF-kappa-B signaling pathway", "PATHWAY:306": "TBC/RABGAPs", "PATHWAY:307": "Apoptotic cleavage of cellular proteins", "PATHWAY:308": "RHOA GTPase cycle", "PATHWAY:309": "Antigen Presentation: Folding, assembly and peptide loading of class I MHC", "PATHWAY:310": "BMAL1:CLOCK,NPAS2 activates circadian gene expression", "PATHWAY:311": "Nicotinamide salvaging", "PATHWAY:312": "NPAS4 regulates expression of target genes", "PATHWAY:313": "Retrograde transport at the Trans-Golgi-Network", "PATHWAY:314": "SARS-CoV-2 activates/modulates innate and adaptive immune responses", "PATHWAY:315": "Interleukin-35 Signalling", "PATHWAY:316": "Interleukin-27 signaling", "PATHWAY:317": "Other semaphorin interactions", "PATHWAY:318": "HCMV Early Events", "PATHWAY:319": "Regulation of RAS by GAPs", "PATHWAY:320": "Lysine catabolism", "PATHWAY:321": "Metabolism of Angiotensinogen to Angiotensins", "PATHWAY:322": "RHOF GTPase cycle", "PATHWAY:323": "G alpha (q) signalling events", "PATHWAY:324": "P2Y receptors", "PATHWAY:325": "Gluconeogenesis", "PATHWAY:326": "Urea cycle", "PATHWAY:327": "G0 and Early G1", "PATHWAY:328": "Telomere Extension By Telomerase", "PATHWAY:329": "Activation of ATR in response to replication stress", "PATHWAY:330": "Regulation of APC/C activators between G1/S and early anaphase", "PATHWAY:331": "SCF(Skp2)-mediated degradation of p27/p21", "PATHWAY:332": "Senescence-Associated Secretory Phenotype (SASP)", "PATHWAY:333": "TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest", "PATHWAY:334": "G2 Phase", "PATHWAY:335": "Orc1 removal from chromatin", "PATHWAY:336": "Activation of the pre-replicative complex", "PATHWAY:337": "CDK-mediated phosphorylation and removal of Cdc6", "PATHWAY:338": "Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes", "PATHWAY:339": "Cyclin D associated events in G1", "PATHWAY:340": "Cyclin A/B1/B2 associated events during G2/M transition", "PATHWAY:341": "p53-Dependent G1 DNA Damage Response", "PATHWAY:342": "PTK6 Regulates Cell Cycle", "PATHWAY:343": "Transcriptional regulation of granulopoiesis", "PATHWAY:344": "Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)", "PATHWAY:345": "The canonical retinoid cycle in rods (twilight vision)", "PATHWAY:346": "RA biosynthesis pathway", "PATHWAY:347": "Smooth Muscle Contraction", "PATHWAY:348": "Transport of the SLBP independent Mature mRNA", "PATHWAY:349": "Transport of the SLBP Dependant Mature mRNA", "PATHWAY:350": "Transport of Mature mRNA Derived from an Intronless Transcript", "PATHWAY:351": "Transport of Mature mRNA derived from an Intron-Containing Transcript", "PATHWAY:352": "mRNA 3'-end processing", "PATHWAY:353": "RNA Polymerase II Transcription Termination", "PATHWAY:354": "Oncogene Induced Senescence", "PATHWAY:355": "RMTs methylate histone arginines", "PATHWAY:356": "Ubiquitin-dependent degradation of Cyclin D", "PATHWAY:357": "Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4", "PATHWAY:358": "Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6", "PATHWAY:359": "Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4", "PATHWAY:360": "Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6", "PATHWAY:361": "Drug-mediated inhibition of CDK4/CDK6 activity", "PATHWAY:362": "Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein", "PATHWAY:363": "Defective ALG3 causes CDG-1d", "PATHWAY:364": "Protein methylation", "PATHWAY:365": "Activation of NF-kappaB in B cells", "PATHWAY:366": "Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha", "PATHWAY:367": "ER-Phagosome pathway", "PATHWAY:368": "Cross-presentation of soluble exogenous antigens (endosomes)", "PATHWAY:369": "Autodegradation of Cdh1 by Cdh1:APC/C", "PATHWAY:370": "SCF-beta-TrCP mediated degradation of Emi1", "PATHWAY:371": "APC/C:Cdc20 mediated degradation of Securin", "PATHWAY:372": "APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1", "PATHWAY:373": "Cdc20:Phospho-APC/C mediated degradation of Cyclin A", "PATHWAY:374": "Vpu mediated degradation of CD4", "PATHWAY:375": "Vif-mediated degradation of APOBEC3G", "PATHWAY:376": "Degradation of beta-catenin by the destruction complex", "PATHWAY:377": "Downstream TCR signaling", "PATHWAY:378": "Regulation of activated PAK-2p34 by proteasome mediated degradation", "PATHWAY:379": "Autodegradation of the E3 ubiquitin ligase COP1", "PATHWAY:380": "Regulation of ornithine decarboxylase (ODC)", "PATHWAY:381": "AUF1 (hnRNP D0) binds and destabilizes mRNA", "PATHWAY:382": "Asymmetric localization of PCP proteins", "PATHWAY:383": "Degradation of AXIN", "PATHWAY:384": "Degradation of DVL", "PATHWAY:385": "Hedgehog ligand biogenesis", "PATHWAY:386": "Hh mutants are degraded by ERAD", "PATHWAY:387": "Dectin-1 mediated noncanonical NF-kB signaling", "PATHWAY:388": "CLEC7A (Dectin-1) signaling", "PATHWAY:389": "Degradation of GLI1 by the proteasome", "PATHWAY:390": "Degradation of GLI2 by the proteasome", "PATHWAY:391": "GLI3 is processed to GLI3R by the proteasome", "PATHWAY:392": "Hedgehog 'on' state", "PATHWAY:393": "TNFR2 non-canonical NF-kB pathway", "PATHWAY:394": "NIK-->noncanonical NF-kB signaling", "PATHWAY:395": "Defective CFTR causes cystic fibrosis", "PATHWAY:396": "MAPK6/MAPK4 signaling", "PATHWAY:397": "UCH proteinases", "PATHWAY:398": "Assembly of the pre-replicative complex", "PATHWAY:399": "G2/M Checkpoints", "PATHWAY:400": "Ubiquitin Mediated Degradation of Phosphorylated Cdc25A", "PATHWAY:401": "The role of GTSE1 in G2/M progression after G2 checkpoint", "PATHWAY:402": "FBXL7 down-regulates AURKA during mitotic entry and in early mitosis", "PATHWAY:403": "RUNX1 regulates transcription of genes involved in differentiation of HSCs", "PATHWAY:404": "Regulation of RUNX2 expression and activity", "PATHWAY:405": "Regulation of RUNX3 expression and activity", "PATHWAY:406": "Regulation of expression of SLITs and ROBOs", "PATHWAY:407": "Interleukin-1 signaling", "PATHWAY:408": "Negative regulation of NOTCH4 signaling", "PATHWAY:409": "GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2", "PATHWAY:410": "Somitogenesis", "PATHWAY:411": "Collagen degradation", "PATHWAY:412": "Signaling by EGFR", "PATHWAY:413": "Activated NOTCH1 Transmits Signal to the Nucleus", "PATHWAY:414": "Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant", "PATHWAY:415": "Constitutive Signaling by NOTCH1 HD Domain Mutants", "PATHWAY:416": "NOTCH2 Activation and Transmission of Signal to the Nucleus", "PATHWAY:417": "EPH-ephrin mediated repulsion of cells", "PATHWAY:418": "NOTCH3 Activation and Transmission of Signal to the Nucleus", "PATHWAY:419": "NOTCH4 Activation and Transmission of Signal to the Nucleus", "PATHWAY:420": "DARPP-32 events", "PATHWAY:421": "CRMPs in Sema3A signaling", "PATHWAY:422": "NGF-stimulated transcription", "PATHWAY:423": "Activated NTRK2 signals through CDK5", "PATHWAY:424": "G alpha (s) signalling events", "PATHWAY:425": "Calcitonin-like ligand receptors", "PATHWAY:426": "ER Quality Control Compartment (ERQC)", "PATHWAY:427": "Regulation of RUNX1 Expression and Activity", "PATHWAY:428": "SUMOylation of SUMOylation proteins", "PATHWAY:429": "SUMOylation of immune response proteins", "PATHWAY:430": "Synaptic adhesion-like molecules", "PATHWAY:431": "RHOB GTPase cycle", "PATHWAY:432": "RHOC GTPase cycle", "PATHWAY:433": "Metalloprotease DUBs", "PATHWAY:434": "Interconversion of nucleotide di- and triphosphates", "PATHWAY:435": "Formation of RNA Pol II elongation complex ", "PATHWAY:436": "Formation of the Early Elongation Complex", "PATHWAY:437": "Formation of HIV elongation complex in the absence of HIV Tat", "PATHWAY:438": "Formation of the HIV-1 Early Elongation Complex", "PATHWAY:439": "RNA Pol II CTD phosphorylation and interaction with CE during HIV infection", "PATHWAY:440": "HIV Transcription Initiation", "PATHWAY:441": "RNA Polymerase II HIV Promoter Escape", "PATHWAY:442": "Transcription of the HIV genome", "PATHWAY:443": "Formation of HIV-1 elongation complex containing HIV-1 Tat", "PATHWAY:444": "Tat-mediated elongation of the HIV-1 transcript", "PATHWAY:445": "RNA Polymerase II Pre-transcription Events", "PATHWAY:446": "TP53 Regulates Transcription of DNA Repair Genes", "PATHWAY:447": "RNA polymerase II transcribes snRNA genes", "PATHWAY:448": "mRNA Capping", "PATHWAY:449": "RNA Polymerase I Transcription Initiation", "PATHWAY:450": "RNA Polymerase I Promoter Escape", "PATHWAY:451": "RNA Polymerase II Promoter Escape", "PATHWAY:452": "RNA Polymerase II Transcription Pre-Initiation And Promoter Opening", "PATHWAY:453": "RNA Polymerase II Transcription Initiation", "PATHWAY:454": "RNA Polymerase II Transcription Elongation", "PATHWAY:455": "RNA Polymerase II Transcription Initiation And Promoter Clearance", "PATHWAY:456": "RNA Pol II CTD phosphorylation and interaction with CE", "PATHWAY:457": "Triglyceride catabolism", "PATHWAY:458": "Lipophagy", "PATHWAY:459": "RHOBTB3 ATPase cycle", "PATHWAY:460": "Intra-Golgi traffic", "PATHWAY:461": "Ubiquinol biosynthesis", "PATHWAY:462": "Post-translational modification: synthesis of GPI-anchored proteins", "PATHWAY:463": "Processing of Capped Intron-Containing Pre-mRNA", "PATHWAY:464": "Association of TriC/CCT with target proteins during biosynthesis", "PATHWAY:465": "SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription", "PATHWAY:466": "Mitochondrial translation initiation", "PATHWAY:467": "Mitochondrial translation termination", "PATHWAY:468": "Ca2+ activated K+ channels", "PATHWAY:469": "cGMP effects", "PATHWAY:470": "Molybdenum cofactor biosynthesis", "PATHWAY:471": "Threonine catabolism", "PATHWAY:472": "tRNA processing in the nucleus", "PATHWAY:473": "Conjugation of salicylate with glycine", "PATHWAY:474": "Conjugation of benzoate with glycine", "PATHWAY:475": "Aspirin ADME", "PATHWAY:476": "Pausing and recovery of Tat-mediated HIV elongation", "PATHWAY:477": "Tat-mediated HIV elongation arrest and recovery", "PATHWAY:478": "HIV elongation arrest and recovery", "PATHWAY:479": "Pausing and recovery of HIV elongation", "PATHWAY:480": "Interactions of Tat with host cellular proteins", "PATHWAY:481": "Estrogen-dependent gene expression", "PATHWAY:482": "RHOBTB2 GTPase cycle", "PATHWAY:483": "RHOBTB1 GTPase cycle", "PATHWAY:484": "EGFR downregulation", "PATHWAY:485": "Spry regulation of FGF signaling", "PATHWAY:486": "Negative regulation of MET activity", "PATHWAY:487": "Cargo recognition for clathrin-mediated endocytosis", "PATHWAY:488": "InlB-mediated entry of Listeria monocytogenes into host cell", "PATHWAY:489": "RHOU GTPase cycle", "PATHWAY:490": "MAP2K and MAPK activation", "PATHWAY:491": "Signaling by moderate kinase activity BRAF mutants", "PATHWAY:492": "Signaling by high-kinase activity BRAF mutants", "PATHWAY:493": "Paradoxical activation of RAF signaling by kinase inactive BRAF", "PATHWAY:494": "Signaling downstream of RAS mutants", "PATHWAY:495": "Signaling by RAF1 mutants", "PATHWAY:496": "Interleukin-4 and Interleukin-13 signaling", "PATHWAY:497": "Transcriptional  activation of  cell cycle inhibitor p21 ", "PATHWAY:498": "TFAP2 (AP-2) family regulates transcription of cell cycle factors", "PATHWAY:499": "RUNX3 regulates CDKN1A transcription", "PATHWAY:500": "FOXO-mediated transcription of cell cycle genes", "PATHWAY:501": "STAT5 activation downstream of FLT3 ITD mutants", "PATHWAY:502": "Signaling by FLT3 fusion proteins", "PATHWAY:503": "RHO GTPases activate CIT", "PATHWAY:504": "Antagonism of Activin by Follistatin", "PATHWAY:505": "Expression and translocation of olfactory receptors", "PATHWAY:506": "Recognition and association of DNA glycosylase with site containing an affected pyrimidine", "PATHWAY:507": "Cleavage of the damaged pyrimidine ", "PATHWAY:508": "Recognition and association of DNA glycosylase with site containing an affected purine", "PATHWAY:509": "Cleavage of the damaged purine", "PATHWAY:510": "Meiotic synapsis", "PATHWAY:511": "Packaging Of Telomere Ends", "PATHWAY:512": "Formation of the beta-catenin:TCF transactivating complex", "PATHWAY:513": "PRC2 methylates histones and DNA", "PATHWAY:514": "SIRT1 negatively regulates rRNA expression", "PATHWAY:515": "ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression", "PATHWAY:516": "B-WICH complex positively regulates rRNA expression", "PATHWAY:517": "DNA methylation", "PATHWAY:518": "Transcriptional regulation by small RNAs", "PATHWAY:519": "Activation of anterior HOX genes in hindbrain development during early embryogenesis", "PATHWAY:520": "Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3", "PATHWAY:521": "Assembly of the ORC complex at the origin of replication", "PATHWAY:522": "RNA Polymerase I Promoter Opening", "PATHWAY:523": "RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function", "PATHWAY:524": "Inhibition of DNA recombination at telomere", "PATHWAY:525": "Defective pyroptosis", "PATHWAY:526": "Circadian Clock", "PATHWAY:527": "Cysteine formation from homocysteine", "PATHWAY:528": "Metabolism of ingested SeMet, Sec, MeSec into H2Se", "PATHWAY:529": "Downregulation of TGF-beta receptor signaling", "PATHWAY:530": "Downregulation of ERBB2 signaling", "PATHWAY:531": "Establishment of Sister Chromatid Cohesion", "PATHWAY:532": "Cohesin Loading onto Chromatin", "PATHWAY:533": "WNT mediated activation of DVL", "PATHWAY:534": "HDACs deacetylate histones", "PATHWAY:535": "G alpha (z) signalling events", "PATHWAY:536": "Apoptotic factor-mediated response", "PATHWAY:537": "SUMOylation of transcription factors", "PATHWAY:538": "Stabilization of p53", "PATHWAY:539": "Transcriptional Regulation by VENTX", "PATHWAY:540": "Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function", "PATHWAY:541": "Evasion of Oncogene Induced Senescence Due to p14ARF Defects", "PATHWAY:542": "Evasion of Oxidative Stress Induced Senescence Due to p14ARF Defects", "PATHWAY:543": "Nuclear events mediated by NFE2L2", "PATHWAY:544": "Branched-chain amino acid catabolism", "PATHWAY:545": "Activation of RAC1", "PATHWAY:546": "RHOQ GTPase cycle", "PATHWAY:547": "RHOH GTPase cycle", "PATHWAY:548": "RHOG GTPase cycle", "PATHWAY:549": "RHOJ GTPase cycle", "PATHWAY:550": "RHOV GTPase cycle", "PATHWAY:551": "C6 deamination of adenosine", "PATHWAY:552": "Formation of editosomes by ADAR proteins", "PATHWAY:553": "Interferon alpha/beta signaling", "PATHWAY:554": "RNA Polymerase III Abortive And Retractive Initiation", "PATHWAY:555": "RNA Polymerase III Transcription Initiation From Type 3 Promoter", "PATHWAY:556": "ROS and RNS production in phagocytes", "PATHWAY:557": "Insulin receptor recycling", "PATHWAY:558": "Transferrin endocytosis and recycling", "PATHWAY:559": "Amino acids regulate mTORC1", "PATHWAY:560": "Ion channel transport", "PATHWAY:561": "Lewis blood group biosynthesis", "PATHWAY:562": "Ovarian tumor domain proteases", "PATHWAY:563": "Laminin interactions", "PATHWAY:564": "Non-integrin membrane-ECM interactions", "PATHWAY:565": "MET activates PTK2 signaling", "PATHWAY:566": "MTOR signalling", "PATHWAY:567": "mTORC1-mediated signalling", "PATHWAY:568": "Energy dependent regulation of mTOR by LKB1-AMPK", "PATHWAY:569": "Signal regulatory protein family interactions", "PATHWAY:570": "Glutathione conjugation", "PATHWAY:571": "Formation of xylulose-5-phosphate", "PATHWAY:572": "Keratan sulfate biosynthesis", "PATHWAY:573": "MyD88:MAL(TIRAP) cascade initiated on plasma membrane", "PATHWAY:574": "Toll Like Receptor TLR6:TLR2 Cascade", "PATHWAY:575": "MyD88 deficiency (TLR2/4)", "PATHWAY:576": "IRAK4 deficiency (TLR2/4)", "PATHWAY:577": "Regulation of TLR by endogenous ligand", "PATHWAY:578": "Signaling by ALK fusions and activated point mutants", "PATHWAY:579": "ABC transporters in lipid homeostasis", "PATHWAY:580": "Mitochondrial tRNA aminoacylation", "PATHWAY:581": "Degradation of cysteine and homocysteine", "PATHWAY:582": "Mitochondrial calcium ion transport", "PATHWAY:583": "Processing of SMDT1", "PATHWAY:584": "Trafficking of AMPA receptors", "PATHWAY:585": "LGI-ADAM interactions", "PATHWAY:586": "Presynaptic depolarization and calcium channel opening", "PATHWAY:587": "Regulation of gene expression by Hypoxia-inducible Factor", "PATHWAY:588": "TFAP2 (AP-2) family regulates transcription of other transcription factors", "PATHWAY:589": "Activation of the TFAP2 (AP-2) family of transcription factors", "PATHWAY:590": "Sema3A PAK dependent Axon repulsion", "PATHWAY:591": "SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion", "PATHWAY:592": "Translocation of SLC2A4 (GLUT4) to the plasma membrane", "PATHWAY:593": "Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane", "PATHWAY:594": "Formation of tubulin folding intermediates by CCT/TriC", "PATHWAY:595": "Post-chaperonin tubulin folding pathway", "PATHWAY:596": "Recycling pathway of L1", "PATHWAY:597": "Hedgehog 'off' state", "PATHWAY:598": "Intraflagellar transport", "PATHWAY:599": "RHO GTPases activate IQGAPs", "PATHWAY:600": "Carboxyterminal post-translational modifications of tubulin", "PATHWAY:601": "Assembly and cell surface presentation of NMDA receptors", "PATHWAY:602": "Activation of AMPK downstream of NMDARs", "PATHWAY:603": "Cytosolic sulfonation of small molecules", "PATHWAY:604": "Prefoldin mediated transfer of substrate  to CCT/TriC", "PATHWAY:605": "Butyrophilin (BTN) family interactions", "PATHWAY:606": "Synthesis of PC", "PATHWAY:607": "Synthesis of PE", "PATHWAY:608": "EPHA-mediated growth cone collapse", "PATHWAY:609": "Sema4D induced cell migration and growth-cone collapse", "PATHWAY:610": "RHO GTPases activate PKNs", "PATHWAY:611": "RHO GTPases Activate ROCKs", "PATHWAY:612": "RHO GTPases activate PAKs", "PATHWAY:613": "NOD1/2 Signaling Pathway", "PATHWAY:614": "TAK1-dependent IKK and NF-kappa-B activation  ", "PATHWAY:615": "activated TAK1 mediates p38 MAPK activation", "PATHWAY:616": "JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1", "PATHWAY:617": "Inactivation of APC/C via direct inhibition of the APC/C complex", "PATHWAY:618": "APC/C:Cdc20 mediated degradation of Cyclin B", "PATHWAY:619": "Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase", "PATHWAY:620": "APC/C:Cdc20 mediated degradation of mitotic proteins", "PATHWAY:621": "Phosphorylation of the APC/C", "PATHWAY:622": "APC-Cdc20 mediated degradation of Nek2A", "PATHWAY:623": "Aberrant regulation of mitotic exit in cancer due to RB1 defects", "PATHWAY:624": "TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain", "PATHWAY:625": "TNFR1-mediated ceramide production", "PATHWAY:626": "Synthesis of PI", "PATHWAY:627": "SUMOylation of DNA replication proteins", "PATHWAY:628": "Pre-NOTCH Processing in Golgi", "PATHWAY:629": "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion", "PATHWAY:630": "Regulation of insulin secretion", "PATHWAY:631": "Nuclear signaling by ERBB4", "PATHWAY:632": "Signaling by Hippo", "PATHWAY:633": "YAP1- and WWTR1 (TAZ)-stimulated gene expression", "PATHWAY:634": "RUNX3 regulates YAP1-mediated transcription", "PATHWAY:635": "EGR2 and SOX10-mediated initiation of Schwann cell myelination", "PATHWAY:636": "Formation of axial mesoderm", "PATHWAY:637": "Defective B3GALTL causes PpS", "PATHWAY:638": "O-glycosylation of TSR domain-containing proteins", "PATHWAY:639": "Regulation of TP53 Activity through Methylation", "PATHWAY:640": "Regulation of cholesterol biosynthesis by SREBP (SREBF)", "PATHWAY:641": "eNOS activation", "PATHWAY:642": "HATs acetylate histones", "PATHWAY:643": "Formation of WDR5-containing histone-modifying complexes", "PATHWAY:644": "Mitochondrial Fatty Acid Beta-Oxidation", "PATHWAY:645": "Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)", "PATHWAY:646": "GPVI-mediated activation cascade", "PATHWAY:647": "FCERI mediated MAPK activation", "PATHWAY:648": "FCERI mediated Ca+2 mobilization", "PATHWAY:649": "TICAM1,TRAF6-dependent induction of TAK1 complex", "PATHWAY:650": "IRAK2 mediated activation of TAK1 complex", "PATHWAY:651": "Alpha-protein kinase 1 signaling pathway", "PATHWAY:652": "PTK6 promotes HIF1A stabilization", "PATHWAY:653": "Translesion synthesis by REV1", "PATHWAY:654": "Translesion synthesis by POLK", "PATHWAY:655": "Translesion synthesis by POLI", "PATHWAY:656": "Cell surface interactions at the vascular wall", "PATHWAY:657": "SARS-CoV-1 activates/modulates innate immune responses", "PATHWAY:658": "Formation of ATP by chemiosmotic coupling", "PATHWAY:659": "Cristae formation", "PATHWAY:660": "Synthesis of active ubiquitin: roles of E1 and E2 enzymes", "PATHWAY:661": "Alpha-oxidation of phytanate", "PATHWAY:662": "Class I peroxisomal membrane protein import", "PATHWAY:663": "Sodium/Proton exchangers", "PATHWAY:664": "Defective SLC9A6 causes  X-linked, syndromic mental retardation,, Christianson type (MRXSCH)", "PATHWAY:665": "L13a-mediated translational silencing of Ceruloplasmin expression", "PATHWAY:666": "Translation initiation complex formation", "PATHWAY:667": "Formation of a pool of free 40S subunits", "PATHWAY:668": "Formation of the ternary complex, and subsequently, the 43S complex", "PATHWAY:669": "Ribosomal scanning and start codon recognition", "PATHWAY:670": "GTP hydrolysis and joining of the 60S ribosomal subunit", "PATHWAY:671": "Role of ABL in ROBO-SLIT signaling", "PATHWAY:672": "CREB3 factors activate genes", "PATHWAY:673": "Class B/2 (Secretin family receptors)", "PATHWAY:674": "Collagen biosynthesis and modifying enzymes", "PATHWAY:675": "Serotonin Neurotransmitter Release Cycle", "PATHWAY:676": "Norepinephrine Neurotransmitter Release Cycle", "PATHWAY:677": "Glutamate Neurotransmitter Release Cycle", "PATHWAY:678": "Dopamine Neurotransmitter Release Cycle", "PATHWAY:679": "Acetylcholine Neurotransmitter Release Cycle", "PATHWAY:680": "RORA activates gene expression", "PATHWAY:681": "Transcriptional activation of mitochondrial biogenesis", "PATHWAY:682": "Activation of gene expression by SREBF (SREBP)", "PATHWAY:683": "Regulation of lipid metabolism by PPARalpha", "PATHWAY:684": "TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest", "PATHWAY:685": "Heme signaling", "PATHWAY:686": "Recycling of bile acids and salts", "PATHWAY:687": "Synthesis of bile acids and bile salts", "PATHWAY:688": "Synthesis of bile acids and bile salts via 27-hydroxycholesterol", "PATHWAY:689": "Endogenous sterols", "PATHWAY:690": "RND3 GTPase cycle", "PATHWAY:691": "Sema4D mediated inhibition of cell attachment and migration", "PATHWAY:692": "ATF4 activates genes in response to endoplasmic reticulum  stress", "PATHWAY:693": "Response of EIF2AK4 (GCN2) to amino acid deficiency", "PATHWAY:694": "Response of EIF2AK1 (HRI) to heme deficiency", "PATHWAY:695": "Nuclear events stimulated by ALK signaling in cancer", "PATHWAY:696": "Elastic fibre formation", "PATHWAY:697": "Molecules associated with elastic fibres", "PATHWAY:698": "Cardiogenesis", "PATHWAY:699": "Scavenging by Class F Receptors", "PATHWAY:700": "Iron uptake and transport", "PATHWAY:701": "Common Pathway of Fibrin Clot Formation", "PATHWAY:702": "ChREBP activates metabolic gene expression", "PATHWAY:703": "Defective SLC35A1 causes congenital disorder of glycosylation 2F (CDG2F)", "PATHWAY:704": "Defective SLC35A1 causes congenital disorder of glycosylation 2F (CDG2F)", "PATHWAY:705": "Transport of nucleotide sugars", "PATHWAY:706": "Vitamin B1 (thiamin) metabolism", "PATHWAY:707": "Chemokine receptors bind chemokines", "PATHWAY:708": "Type II Na+/Pi cotransporters", "PATHWAY:709": "Defective SLC34A2 causes pulmonary alveolar microlithiasis (PALM)", "PATHWAY:710": "Surfactant metabolism", "PATHWAY:711": "Defective SLC34A2 causes PALM", "PATHWAY:712": "Folding of actin by CCT/TriC", "PATHWAY:713": "Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding", "PATHWAY:714": "BBSome-mediated cargo-targeting to cilium", "PATHWAY:715": "LDL clearance", "PATHWAY:716": "Lectin pathway of complement activation", "PATHWAY:717": "Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2", "PATHWAY:718": "Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1", "PATHWAY:719": "O-linked glycosylation", "PATHWAY:720": "Detoxification of Reactive Oxygen Species", "PATHWAY:721": "Metabolism of folate and pterines", "PATHWAY:722": "Signaling by NODAL", "PATHWAY:723": "Signaling by Activin", "PATHWAY:724": "Heme degradation", "PATHWAY:725": "Defective SLCO1B1 causes hyperbilirubinemia, Rotor type (HBLRR)", "PATHWAY:726": "Transport of organic anions", "PATHWAY:727": "Atorvastatin ADME", "PATHWAY:728": "Deadenylation of mRNA", "PATHWAY:729": "Purine ribonucleoside monophosphate biosynthesis", "PATHWAY:730": "Maturation of protein 3a", "PATHWAY:731": "Maturation of spike protein", "PATHWAY:732": "Maturation of protein 3a", "PATHWAY:733": "Neurexins and neuroligins", "PATHWAY:734": "Cytosolic sensors of pathogen-associated DNA ", "PATHWAY:735": "RNA Polymerase III Chain Elongation", "PATHWAY:736": "RNA Polymerase III Transcription Termination", "PATHWAY:737": "RNA Polymerase III Transcription Initiation From Type 1 Promoter", "PATHWAY:738": "RNA Polymerase III Transcription Initiation From Type 2 Promoter", "PATHWAY:739": "Ephrin signaling", "PATHWAY:740": "The NLRP3 inflammasome", "PATHWAY:741": "Regulation of FOXO transcriptional activity by acetylation", "PATHWAY:742": "Purinergic signaling in leishmaniasis infection", "PATHWAY:743": "Polo-like kinase mediated events", "PATHWAY:744": "Specification of primordial germ cells", "PATHWAY:745": "Regulation of signaling by NODAL", "PATHWAY:746": "Insulin processing", "PATHWAY:747": "VxPx cargo-targeting to cilium", "PATHWAY:748": "Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA", "PATHWAY:749": "CaMK IV-mediated phosphorylation of CREB", "PATHWAY:750": "CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde", "PATHWAY:751": "Activation of RAC1 downstream of NMDARs", "PATHWAY:752": "TP53 Regulates Transcription of Genes Involved in Cytochrome C Release", "PATHWAY:753": "MET Receptor Activation", "PATHWAY:754": "Signaling by MST1", "PATHWAY:755": "Cholesterol biosynthesis", "PATHWAY:756": "PTK6 Regulates Proteins Involved in RNA Processing", "PATHWAY:757": "Phase I - Functionalization of compounds", "PATHWAY:758": "Physiological factors", "PATHWAY:759": "E3 ubiquitin ligases ubiquitinate target proteins", "PATHWAY:760": "Thromboxane signalling through TP receptor", "PATHWAY:761": "Thrombin signalling through proteinase activated receptors (PARs)", "PATHWAY:762": "TNFs bind their physiological receptors", "PATHWAY:763": "TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway", "PATHWAY:764": "Chondroitin sulfate biosynthesis", "PATHWAY:765": "CS/DS degradation", "PATHWAY:766": "Defective CHST3 causes SEDCJD", "PATHWAY:767": "Defective CHST14 causes EDS, musculocontractural type", "PATHWAY:768": "Defective CHSY1 causes TPBS", "PATHWAY:769": "Activation of G protein gated Potassium channels", "PATHWAY:770": "G-protein activation", "PATHWAY:771": "ADP signalling through P2Y purinoceptor 12", "PATHWAY:772": "Prostacyclin signalling through prostacyclin receptor", "PATHWAY:773": "Adrenaline,noradrenaline inhibits insulin secretion", "PATHWAY:774": "Ca2+ pathway", "PATHWAY:775": "G beta:gamma signalling through PLC beta", "PATHWAY:776": "ADP signalling through P2Y purinoceptor 1", "PATHWAY:777": "Glucagon-type ligand receptors", "PATHWAY:778": "Vasopressin regulates renal water homeostasis via Aquaporins", "PATHWAY:779": "Presynaptic function of Kainate receptors", "PATHWAY:780": "G beta:gamma signalling through BTK", "PATHWAY:781": "G beta:gamma signalling through CDC42", "PATHWAY:782": "Extra-nuclear estrogen signaling", "PATHWAY:783": "GPER1 signaling", "PATHWAY:784": "ADORA2B mediated anti-inflammatory cytokines production", "PATHWAY:785": "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits", "PATHWAY:786": "Cholesterol biosynthesis via desmosterol", "PATHWAY:787": "Cholesterol biosynthesis via lathosterol", "PATHWAY:788": "Tight junction interactions", "PATHWAY:789": "Trafficking and processing of endosomal TLR", "PATHWAY:790": "Glucagon signaling in metabolic regulation", "PATHWAY:791": "PKA activation", "PATHWAY:792": "PKA activation in glucagon signalling", "PATHWAY:793": "Adenylate cyclase activating pathway", "PATHWAY:794": "Adenylate cyclase inhibitory pathway", "PATHWAY:795": "CREB1 phosphorylation through the activation of Adenylate Cyclase", "PATHWAY:796": "FCGR3A-mediated IL10 synthesis", "PATHWAY:797": "LDL remodeling", "PATHWAY:798": "HDL remodeling", "PATHWAY:799": "Recognition of DNA damage by PCNA-containing replication complex", "PATHWAY:800": "Processive synthesis on the C-strand of the telomere", "PATHWAY:801": "Telomere C-strand (Lagging Strand) Synthesis", "PATHWAY:802": "Removal of the Flap Intermediate from the C-strand", "PATHWAY:803": "Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)", "PATHWAY:804": "Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)", "PATHWAY:805": "PCNA-Dependent Long Patch Base Excision Repair", "PATHWAY:806": "Termination of translesion DNA synthesis", "PATHWAY:807": "Gap-filling DNA repair synthesis and ligation in GG-NER", "PATHWAY:808": "Polymerase switching", "PATHWAY:809": "Removal of the Flap Intermediate", "PATHWAY:810": "Processive synthesis on the lagging strand", "PATHWAY:811": "Signaling by ERBB2", "PATHWAY:812": "Signaling by ERBB4", "PATHWAY:813": "SHC1 events in ERBB2 signaling", "PATHWAY:814": "PI3K events in ERBB4 signaling", "PATHWAY:815": "SHC1 events in ERBB4 signaling", "PATHWAY:816": "GRB2 events in ERBB2 signaling", "PATHWAY:817": "PI3K events in ERBB2 signaling", "PATHWAY:818": "Constitutive Signaling by Aberrant PI3K in Cancer", "PATHWAY:819": "ERBB2 Regulates Cell Motility", "PATHWAY:820": "PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling", "PATHWAY:821": "ERBB2 Activates PTK6 Signaling", "PATHWAY:822": "Signaling by ERBB2 KD Mutants", "PATHWAY:823": "Signaling by ERBB2 TMD/JMD mutants", "PATHWAY:824": "Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation", "PATHWAY:825": "Glucuronidation", "PATHWAY:826": "Cation-coupled Chloride cotransporters", "PATHWAY:827": "RND2 GTPase cycle", "PATHWAY:828": "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)", "PATHWAY:829": "Attenuation phase", "PATHWAY:830": "Aryl hydrocarbon receptor signalling", "PATHWAY:831": "ESR-mediated signaling", "PATHWAY:832": "Ficolins bind to repetitive carbohydrate structures on the target cell surface", "PATHWAY:833": "CHL1 interactions", "PATHWAY:834": "ISG15 antiviral mechanism", "PATHWAY:835": "Rev-mediated nuclear export of HIV RNA", "PATHWAY:836": "Transport of Ribonucleoproteins into the Host Nucleus", "PATHWAY:837": "NS1 Mediated Effects on Host Pathways", "PATHWAY:838": "Viral Messenger RNA Synthesis", "PATHWAY:839": "NEP/NS2 Interacts with the Cellular Export Machinery", "PATHWAY:840": "Regulation of Glucokinase by Glucokinase Regulatory Protein", "PATHWAY:841": "Nuclear import of Rev protein", "PATHWAY:842": "Vpr-mediated nuclear import of PICs", "PATHWAY:843": "SUMOylation of ubiquitinylation proteins", "PATHWAY:844": "Nuclear Pore Complex (NPC) Disassembly", "PATHWAY:845": "Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC)", "PATHWAY:846": "HDMs demethylate histones", "PATHWAY:847": "mRNA decay by 3' to 5' exoribonuclease", "PATHWAY:848": "PLC beta mediated events", "PATHWAY:849": "DAG and IP3 signaling", "PATHWAY:850": "Role of phospholipids in phagocytosis", "PATHWAY:851": "VEGFR2 mediated cell proliferation", "PATHWAY:852": "CLEC7A (Dectin-1) induces NFAT activation", "PATHWAY:853": "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers", "PATHWAY:854": "TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain", "PATHWAY:855": "CD163 mediating an anti-inflammatory response", "PATHWAY:856": "MASTL Facilitates Mitotic Progression", "PATHWAY:857": "Activation of NIMA Kinases NEK9, NEK6, NEK7", "PATHWAY:858": "tRNA modification in the nucleus and cytosol", "PATHWAY:859": "RHO GTPases regulate CFTR trafficking", "PATHWAY:860": "Leukotriene receptors", "PATHWAY:861": "LTC4-CYSLTR mediated IL4 production", "PATHWAY:862": "Androgen biosynthesis", "PATHWAY:863": "Mineralocorticoid biosynthesis", "PATHWAY:864": "Glycoprotein hormones", "PATHWAY:865": "Thyroxine biosynthesis", "PATHWAY:866": "Hormone ligand-binding receptors", "PATHWAY:867": "TFAP2 (AP-2) family regulates transcription of growth factors and their receptors", "PATHWAY:868": "Reactions specific to the complex N-glycan synthesis pathway", "PATHWAY:869": "RHO GTPases Activate NADPH Oxidases", "PATHWAY:870": "WNT5:FZD7-mediated leishmania damping", "PATHWAY:871": "GABA synthesis, release, reuptake and degradation", "PATHWAY:872": "FRS-mediated FGFR1 signaling", "PATHWAY:873": "FRS-mediated FGFR2 signaling", "PATHWAY:874": "FRS-mediated FGFR3 signaling", "PATHWAY:875": "FRS-mediated FGFR4 signaling", "PATHWAY:876": "Activated NTRK2 signals through FRS2 and FRS3", "PATHWAY:877": "RND1 GTPase cycle", "PATHWAY:878": "PI3K Cascade", "PATHWAY:879": "Frs2-mediated activation", "PATHWAY:880": "Signaling by ALK", "PATHWAY:881": "PI-3K cascade:FGFR1", "PATHWAY:882": "PI-3K cascade:FGFR2", "PATHWAY:883": "PI-3K cascade:FGFR3", "PATHWAY:884": "PI-3K cascade:FGFR4", "PATHWAY:885": "Negative regulation of FGFR1 signaling", "PATHWAY:886": "Negative regulation of FGFR2 signaling", "PATHWAY:887": "Negative regulation of FGFR3 signaling", "PATHWAY:888": "Negative regulation of FGFR4 signaling", "PATHWAY:889": "Signaling by FGFR2 in disease", "PATHWAY:890": "Signaling by FGFR4 in disease", "PATHWAY:891": "Signaling by FGFR1 in disease", "PATHWAY:892": "Signaling by FGFR3 in disease", "PATHWAY:893": "RET signaling", "PATHWAY:894": "Glycosphingolipid metabolism", "PATHWAY:895": "Histidine catabolism", "PATHWAY:896": "Synthesis of bile acids and bile salts via 24-hydroxycholesterol", "PATHWAY:897": "Transport and synthesis of PAPS", "PATHWAY:898": "Multifunctional anion exchangers", "PATHWAY:899": "Organic anion transport", "PATHWAY:900": "Citric acid cycle (TCA cycle)", "PATHWAY:901": "Fibronectin matrix formation", "PATHWAY:902": "Orexin and neuropeptides FF and QRFP bind to their respective receptors", "PATHWAY:903": "RAB geranylgeranylation", "PATHWAY:904": "Activation of PPARGC1A (PGC-1alpha) by phosphorylation", "PATHWAY:905": "FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes", "PATHWAY:906": "CLEC7A/inflammasome pathway", "PATHWAY:907": "Activation of Matrix Metalloproteinases", "PATHWAY:908": "Hyaluronan uptake and degradation", "PATHWAY:909": "Inhibition of Host mRNA Processing and RNA Silencing", "PATHWAY:910": "Processing of Intronless Pre-mRNAs", "PATHWAY:911": "Olfactory Signaling Pathway", "PATHWAY:912": "Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2", "PATHWAY:913": "Glycerophospholipid catabolism", "PATHWAY:914": "PKMTs methylate histone lysines", "PATHWAY:915": "Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)", "PATHWAY:916": "Pregnenolone biosynthesis", "PATHWAY:917": "SRP-dependent cotranslational protein targeting to membrane", "PATHWAY:918": "Insertion of tail-anchored proteins into the endoplasmic reticulum membrane", "PATHWAY:919": "Serine biosynthesis", "PATHWAY:920": "Fatty acyl-CoA biosynthesis", "PATHWAY:921": "Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex", "PATHWAY:922": "SARS-CoV-1 targets host intracellular signalling and regulatory pathways", "PATHWAY:923": "ALKBH3 mediated reversal of alkylation damage", "PATHWAY:924": "Cell-extracellular matrix interactions", "PATHWAY:925": "Amino acid transport across the plasma membrane", "PATHWAY:926": "Defective SLC27A4 causes ichthyosis prematurity syndrome (IPS)", "PATHWAY:927": "Transport of fatty acids", "PATHWAY:928": "Synthesis of very long-chain fatty acyl-CoAs", "PATHWAY:929": "Interleukin-20 family signaling", "PATHWAY:930": "Glyoxylate metabolism and glycine degradation", "PATHWAY:931": "PIWI-interacting RNA (piRNA) biogenesis", "PATHWAY:932": "TICAM1, RIP1-mediated IKK complex recruitment", "PATHWAY:933": "RIP-mediated NFkB activation via ZBP1", "PATHWAY:934": "TRP channels", "PATHWAY:935": "TLR3-mediated TICAM1-dependent programmed cell death", "PATHWAY:936": "Microbial modulation of RIPK1-mediated regulated necrosis", "PATHWAY:937": "SARS-CoV-1-mediated effects on programmed cell death", "PATHWAY:938": "Postmitotic nuclear pore complex (NPC) reformation", "PATHWAY:939": "Defective LARGE causes MDDGA6 and MDDGB6", "PATHWAY:940": "Signaling by cytosolic FGFR1 fusion mutants", "PATHWAY:941": "Downregulation of ERBB4 signaling", "PATHWAY:942": "Keratan sulfate degradation", "PATHWAY:943": "Defective CHST6 causes MCDC1", "PATHWAY:944": "Defective ST3GAL3 causes MCT12 and EIEE15", "PATHWAY:945": "Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)", "PATHWAY:946": "Interaction With Cumulus Cells And The Zona Pellucida", "PATHWAY:947": "p75NTR negatively regulates cell cycle via SC1", "PATHWAY:948": "Activation of SMO", "PATHWAY:949": "Basigin interactions", "PATHWAY:950": "Defective SLC3A1 causes cystinuria (CSNU)", "PATHWAY:951": "Defective SLC7A9 causes cystinuria (CSNU)", "PATHWAY:952": "Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants", "PATHWAY:953": "Constitutive Signaling by EGFRvIII", "PATHWAY:954": "Constitutive Signaling by Overexpressed ERBB2", "PATHWAY:955": "Drug-mediated inhibition of ERBB2 signaling", "PATHWAY:956": "Resistance of ERBB2 KD mutants to trastuzumab", "PATHWAY:957": "Resistance of ERBB2 KD mutants to sapitinib", "PATHWAY:958": "Resistance of ERBB2 KD mutants to tesevatinib", "PATHWAY:959": "Resistance of ERBB2 KD mutants to neratinib", "PATHWAY:960": "Resistance of ERBB2 KD mutants to osimertinib", "PATHWAY:961": "Resistance of ERBB2 KD mutants to afatinib", "PATHWAY:962": "Resistance of ERBB2 KD mutants to AEE788", "PATHWAY:963": "Resistance of ERBB2 KD mutants to lapatinib", "PATHWAY:964": "Signaling by ERBB2 ECD mutants", "PATHWAY:965": "Drug resistance in ERBB2 TMD/JMD mutants", "PATHWAY:966": "Receptor-type tyrosine-protein phosphatases", "PATHWAY:967": "Interleukin-38 signaling", "PATHWAY:968": "Acyl chain remodelling of PI", "PATHWAY:969": "Prevention of phagosomal-lysosomal fusion", "PATHWAY:970": "mRNA decay by 5' to 3' exoribonuclease", "PATHWAY:971": "Signaling by plasma membrane FGFR1 fusions", "PATHWAY:972": "Synthesis of pyrophosphates in the cytosol", "PATHWAY:973": "Phosphate bond hydrolysis by NUDT proteins", "PATHWAY:974": "Signaling by BMP", "PATHWAY:975": "Integration of provirus", "PATHWAY:976": "2-LTR circle formation", "PATHWAY:977": "Integration of viral DNA into host genomic DNA", "PATHWAY:978": "Autointegration results in viral DNA circles", "PATHWAY:979": "APOBEC3G mediated resistance to HIV-1 infection", "PATHWAY:980": "Digestion of dietary carbohydrate", "PATHWAY:981": "Cellular hexose transport", "PATHWAY:982": "Methylation of MeSeH for excretion", "PATHWAY:983": "TCF dependent signaling in response to WNT", "PATHWAY:984": "Negative regulation of TCF-dependent signaling by WNT ligand antagonists", "PATHWAY:985": "SARS-CoV-2 modulates host translation machinery", "PATHWAY:986": "RAF-independent MAPK1/3 activation", "PATHWAY:987": "Negative regulation of MAPK pathway", "PATHWAY:988": "Signaling by MAPK mutants", "PATHWAY:989": "Peptide chain elongation", "PATHWAY:990": "Viral mRNA Translation", "PATHWAY:991": "Selenocysteine synthesis", "PATHWAY:992": "Eukaryotic Translation Termination", "PATHWAY:993": "Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)", "PATHWAY:994": "Reversible hydration of carbon dioxide", "PATHWAY:995": "Chromatin modifying enzymes", "PATHWAY:996": "Prostanoid ligand receptors", "PATHWAY:997": "Defective MAN1B1 causes MRT15", "PATHWAY:998": "Na+/Cl- dependent neurotransmitter transporters", "PATHWAY:999": "Variant SLC6A14 may confer susceptibility towards obesity", "PATHWAY:1000": "Histamine receptors", "PATHWAY:1001": "Regulation of IFNA/IFNB signaling", "PATHWAY:1002": "Regulation of NF-kappa B signaling", "PATHWAY:1003": "Interleukin-17 signaling", "PATHWAY:1004": "Toxicity of botulinum toxin type C (botC)", "PATHWAY:1005": "Regulation by TREX1", "PATHWAY:1006": "IRF3-mediated induction of type I IFN", "PATHWAY:1007": "Muscarinic acetylcholine receptors", "PATHWAY:1008": "Interaction between L1 and Ankyrins", "PATHWAY:1009": "Phase 0 - rapid depolarisation", "PATHWAY:1010": "Mitochondrial iron-sulfur cluster biogenesis", "PATHWAY:1011": "Electron transport from NADPH to Ferredoxin", "PATHWAY:1012": "Defective CYP11A1 causes AICSR", "PATHWAY:1013": "N-Glycan antennae elongation", "PATHWAY:1014": "Fatty acids", "PATHWAY:1015": "Eicosanoids", "PATHWAY:1016": "Synthesis of Leukotrienes (LT) and Eoxins (EX)", "PATHWAY:1017": "APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway", "PATHWAY:1018": "Synthesis of IP3 and IP4 in the cytosol", "PATHWAY:1019": "Acetylcholine regulates insulin secretion", "PATHWAY:1020": "SARS-CoV-2 modulates autophagy", "PATHWAY:1021": "Acrosome Reaction and Sperm:Oocyte Membrane Binding", "PATHWAY:1022": "Vitamin B2 (riboflavin) metabolism", "PATHWAY:1023": "Highly calcium permeable postsynaptic nicotinic acetylcholine receptors", "PATHWAY:1024": "Highly calcium permeable nicotinic acetylcholine receptors", "PATHWAY:1025": "Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA", "PATHWAY:1026": "Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA", "PATHWAY:1027": "KSRP (KHSRP) binds and destabilizes mRNA", "PATHWAY:1028": "Acyl chain remodeling of DAG and TAG", "PATHWAY:1029": "Arachidonate production from DAG", "PATHWAY:1030": "Agmatine biosynthesis", "PATHWAY:1031": "Highly sodium permeable postsynaptic acetylcholine nicotinic receptors", "PATHWAY:1032": "Miscellaneous substrates", "PATHWAY:1033": "Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)", "PATHWAY:1034": "Defective CYP2U1 causes SPG56", "PATHWAY:1035": "Inositol transporters", "PATHWAY:1036": "IKBKB deficiency causes SCID", "PATHWAY:1037": "IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR)", "PATHWAY:1038": "IkBA variant leads to EDA-ID", "PATHWAY:1039": "MAP3K8 (TPL2)-dependent MAPK1/3 activation", "PATHWAY:1040": "TRAF6 mediated NF-kB activation", "PATHWAY:1041": "NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10", "PATHWAY:1042": "IRAK1 recruits IKK complex", "PATHWAY:1043": "IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation", "PATHWAY:1044": "Intracellular oxygen transport", "PATHWAY:1045": "MECP2 regulates neuronal receptors and channels", "PATHWAY:1046": "RHO GTPases Activate Rhotekin and Rhophilins", "PATHWAY:1047": "Lipid particle organization", "PATHWAY:1048": "Synthesis of PG", "PATHWAY:1049": "STING mediated induction of host immune responses", "PATHWAY:1050": "Creatine metabolism", "PATHWAY:1051": "Regulation of Apoptosis", "PATHWAY:1052": "Transport of inorganic cations/anions and amino acids/oligopeptides", "PATHWAY:1053": "Interleukin-7 signaling", "PATHWAY:1054": "Growth hormone receptor signaling", "PATHWAY:1055": "NOSTRIN mediated eNOS trafficking", "PATHWAY:1056": "NGF-independant TRKA activation", "PATHWAY:1057": "Defective SLC22A12 causes renal hypouricemia 1 (RHUC1)", "PATHWAY:1058": "Synthesis of Dolichyl-phosphate", "PATHWAY:1059": "Defective DHDDS causes RP59", "PATHWAY:1060": "Triglyceride biosynthesis", "PATHWAY:1061": "Conjugation of phenylacetate with glutamine", "PATHWAY:1062": "Assembly of active LPL and LIPC lipase complexes", "PATHWAY:1063": "Chylomicron remodeling", "PATHWAY:1064": "PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1", "PATHWAY:1065": "Netrin-1 signaling", "PATHWAY:1066": "Sperm Motility And Taxes", "PATHWAY:1067": "Activation of AKT2", "PATHWAY:1068": "Scavenging by Class A Receptors", "PATHWAY:1069": "Nef mediated downregulation of CD28 cell surface expression", "PATHWAY:1070": "Nef Mediated CD4 Down-regulation", "PATHWAY:1071": "Nef Mediated CD8 Down-regulation", "PATHWAY:1072": "Gap junction degradation", "PATHWAY:1073": "Formation of annular gap junctions", "PATHWAY:1074": "Trafficking of GluR2-containing AMPA receptors", "PATHWAY:1075": "WNT5A-dependent internalization of FZD4", "PATHWAY:1076": "WNT5A-dependent internalization of FZD2, FZD5 and ROR2", "PATHWAY:1077": "Caspase-mediated cleavage of cytoskeletal proteins", "PATHWAY:1078": "Miscellaneous transport and binding events", "PATHWAY:1079": "Terminal pathway of complement", "PATHWAY:1080": "Vitamin C (ascorbate) metabolism", "PATHWAY:1081": "Sensory perception of sweet, bitter, and umami (glutamate) taste", "PATHWAY:1082": "Sensory perception of salty taste", "PATHWAY:1083": "Digestion of dietary lipid", "PATHWAY:1084": "Tryptophan catabolism", "PATHWAY:1085": "Vitamin D (calciferol) metabolism", "PATHWAY:1086": "Vitamins", "PATHWAY:1087": "Defective CYP27B1 causes VDDR1B", "PATHWAY:1088": "Synthesis of diphthamide-EEF2", "PATHWAY:1089": "Entry of Influenza Virion into Host Cell via Endocytosis", "PATHWAY:1090": "Proton/oligopeptide cotransporters", "PATHWAY:1091": "Serotonin and melatonin biosynthesis", "PATHWAY:1092": "ALK mutants bind TKIs", "PATHWAY:1093": "Induction of Cell-Cell Fusion", "PATHWAY:1094": "ALKBH2 mediated reversal of alkylation damage", "PATHWAY:1095": "RUNX1 regulates transcription of genes involved in differentiation of keratinocytes", "PATHWAY:1096": "Interleukin-10 signaling", "PATHWAY:1097": "Sodium/Calcium exchangers", "PATHWAY:1098": "Defective SLC24A4 causes hypomineralized amelogenesis imperfecta (AI)", "PATHWAY:1099": "Binding and entry of HIV virion", "PATHWAY:1100": "Abacavir metabolism", "PATHWAY:1101": "Ethanol oxidation", "PATHWAY:1102": "Class A/1 (Rhodopsin-like receptors)", "PATHWAY:1103": "Defective ABCC2 causes DJS", "PATHWAY:1104": "TP53 Regulates Transcription of Death Receptors and Ligands", "PATHWAY:1105": "Asparagine N-linked glycosylation", "PATHWAY:1106": "Glutathione synthesis and recycling", "PATHWAY:1107": "Aflatoxin activation and detoxification", "PATHWAY:1108": "The IPAF inflammasome", "PATHWAY:1109": "Activation of the phototransduction cascade", "PATHWAY:1110": "Josephin domain DUBs", "PATHWAY:1111": "PI Metabolism", "PATHWAY:1112": "Complex I biogenesis", "PATHWAY:1113": "Defective CYP4F22 causes ARCI5", "PATHWAY:1114": "Transport of bile salts and organic acids, metal ions and amine compounds", "PATHWAY:1115": "IL-6-type cytokine receptor ligand interactions", "PATHWAY:1116": "Neurofascin interactions", "PATHWAY:1117": "Synthesis of wybutosine at G37 of tRNA(Phe)", "PATHWAY:1118": "Extracellular matrix organization", "PATHWAY:1119": "Assembly of collagen fibrils and other multimeric structures", "PATHWAY:1120": "Integrin cell surface interactions", "PATHWAY:1121": "Anchoring fibril formation", "PATHWAY:1122": "Crosslinking of collagen fibrils", "PATHWAY:1123": "Syndecan interactions", "PATHWAY:1124": "ECM proteoglycans", "PATHWAY:1125": "GP1b-IX-V activation signalling", "PATHWAY:1126": "Platelet Adhesion to exposed collagen", "PATHWAY:1127": "Platelet Aggregation (Plug Formation)", "PATHWAY:1128": "Collagen chain trimerization", "PATHWAY:1129": "Toxicity of botulinum toxin type B (botB)", "PATHWAY:1130": "Signaling by PDGF", "PATHWAY:1131": "NCAM1 interactions", "PATHWAY:1132": "Type I hemidesmosome assembly", "PATHWAY:1133": "rRNA modification in the mitochondrion", "PATHWAY:1134": "Voltage gated Potassium channels", "PATHWAY:1135": "Methylation", "PATHWAY:1136": "Enzymatic degradation of dopamine by COMT", "PATHWAY:1137": "Enzymatic degradation of Dopamine by monoamine oxidase", "PATHWAY:1138": "Metal ion SLC transporters", "PATHWAY:1139": "Fructose catabolism", "PATHWAY:1140": "Transcription of E2F targets under negative control by DREAM complex", "PATHWAY:1141": "Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1", "PATHWAY:1142": "G1/S-Specific Transcription", "PATHWAY:1143": "Sensory perception of sour taste", "PATHWAY:1144": "Proton-coupled monocarboxylate transport", "PATHWAY:1145": "Nicotinate metabolism", "PATHWAY:1146": "Adenosine P1 receptors", "PATHWAY:1147": "SLBP independent Processing of Histone Pre-mRNAs", "PATHWAY:1148": "SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs", "PATHWAY:1149": "Amine ligand-binding receptors", "PATHWAY:1150": "Heme biosynthesis", "PATHWAY:1151": "Defective SLC40A1 causes hemochromatosis 4 (HFE4) (macrophages)", "PATHWAY:1152": "Defective CP causes aceruloplasminemia (ACERULOP)", "PATHWAY:1153": "Carnitine shuttle", "PATHWAY:1154": "Signaling by Retinoic Acid", "PATHWAY:1155": "Membrane binding and targetting of GAG proteins", "PATHWAY:1156": "RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs)", "PATHWAY:1157": "Interconversion of 2-oxoglutarate and 2-hydroxyglutarate", "PATHWAY:1158": "Netrin mediated repulsion signals", "PATHWAY:1159": "MPS IIIC - Sanfilippo syndrome C", "PATHWAY:1160": "PKA-mediated phosphorylation of CREB", "PATHWAY:1161": "CREB phosphorylation", "PATHWAY:1162": "NCAM signaling for neurite out-growth", "PATHWAY:1163": "CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling", "PATHWAY:1164": "Gastrin-CREB signalling pathway via PKC and MAPK", "PATHWAY:1165": "Regulation of MECP2 expression and activity", "PATHWAY:1166": "MECP2 regulates transcription of neuronal ligands", "PATHWAY:1167": "MECP2 regulates transcription factors", "PATHWAY:1168": "Activation of the AP-1 family of transcription factors", "PATHWAY:1169": "LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production", "PATHWAY:1170": "CD209 (DC-SIGN) signaling", "PATHWAY:1171": "RUNX1 regulates transcription of genes involved in differentiation of myeloid cells", "PATHWAY:1172": "TRAF3-dependent IRF activation pathway", "PATHWAY:1173": "NFE2L2 regulating anti-oxidant/detoxification enzymes", "PATHWAY:1174": "NFE2L2 regulates pentose phosphate pathway genes", "PATHWAY:1175": "Signaling by GSK3beta mutants", "PATHWAY:1176": "CTNNB1 S33 mutants aren't phosphorylated", "PATHWAY:1177": "CTNNB1 S37 mutants aren't phosphorylated", "PATHWAY:1178": "CTNNB1 S45 mutants aren't phosphorylated", "PATHWAY:1179": "CTNNB1 T41 mutants aren't phosphorylated", "PATHWAY:1180": "APC truncation mutants have impaired AXIN binding", "PATHWAY:1181": "AXIN missense mutants destabilize the destruction complex", "PATHWAY:1182": "Truncations of AMER1 destabilize the destruction complex", "PATHWAY:1183": "Receptor Mediated Mitophagy", "PATHWAY:1184": "Synthesis, secretion, and deacylation of Ghrelin", "PATHWAY:1185": "Signaling by CSF1 (M-CSF) in myeloid cells", "PATHWAY:1186": "Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)", "PATHWAY:1187": "ARMS-mediated activation", "PATHWAY:1188": "Downstream signal transduction", "PATHWAY:1189": "p130Cas linkage to MAPK signaling for integrins", "PATHWAY:1190": "PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases", "PATHWAY:1191": "MET activates RAP1 and RAC1", "PATHWAY:1192": "MET receptor recycling", "PATHWAY:1193": "Regulation of signaling by CBL", "PATHWAY:1194": "Erythropoietin activates RAS", "PATHWAY:1195": "Signaling by VEGF", "PATHWAY:1196": "SARS-CoV-1 modulates host translation machinery", "PATHWAY:1197": "Classical antibody-mediated complement activation", "PATHWAY:1198": "Activation of BMF and translocation to mitochondria", "PATHWAY:1199": "HSF1-dependent transactivation", "PATHWAY:1200": "vRNA Synthesis", "PATHWAY:1201": "Downregulation of SMAD2/3:SMAD4 transcriptional activity", "PATHWAY:1202": "Defective SLC34A3 causes Hereditary hypophosphatemic rickets with hypercalciuria (HHRH)", "PATHWAY:1203": "Beta oxidation of butanoyl-CoA to acetyl-CoA", "PATHWAY:1204": "Maturation of nucleoprotein", "PATHWAY:1205": "Maturation of nucleoprotein", "PATHWAY:1206": "p38MAPK events", "PATHWAY:1207": "ERK/MAPK targets", "PATHWAY:1208": "DSCAM interactions", "PATHWAY:1209": "Platelet sensitization by LDL", "PATHWAY:1210": "FGFR2b ligand binding and activation", "PATHWAY:1211": "Other interleukin signaling", "PATHWAY:1212": "Interleukin-3, Interleukin-5 and GM-CSF signaling", "PATHWAY:1213": "Interleukin receptor SHC signaling", "PATHWAY:1214": "Defective CSF2RB causes SMDP5", "PATHWAY:1215": "Defective CSF2RA causes SMDP4", "PATHWAY:1216": "Signaling by CSF3 (G-CSF)", "PATHWAY:1217": "Inactivation of CSF3 (G-CSF) signaling", "PATHWAY:1218": "Prolactin receptor signaling", "PATHWAY:1219": "MicroRNA (miRNA) biogenesis", "PATHWAY:1220": "GAB1 signalosome", "PATHWAY:1221": "Phosphorylation of CD3 and TCR zeta chains", "PATHWAY:1222": "Co-inhibition by PD-1", "PATHWAY:1223": "Germ layer formation at gastrulation", "PATHWAY:1224": "Formation of definitive endoderm", "PATHWAY:1225": "Signal transduction by L1", "PATHWAY:1226": "Adrenoceptors", "PATHWAY:1227": "MTF1 activates gene expression", "PATHWAY:1228": "Organic anion transporters", "PATHWAY:1229": "Synthesis of PIPs at the plasma membrane", "PATHWAY:1230": "Release of Hh-Np from the secreting cell", "PATHWAY:1231": "RHO GTPases activate KTN1", "PATHWAY:1232": "IRF3 mediated activation of type 1 IFN", "PATHWAY:1233": "Regulation of innate immune responses to cytosolic DNA", "PATHWAY:1234": "Toll Like Receptor 3 (TLR3) Cascade", "PATHWAY:1235": "TICAM1 deficiency - HSE", "PATHWAY:1236": "TRAF3 deficiency - HSE", "PATHWAY:1237": "Deactivation of the beta-catenin transactivating complex", "PATHWAY:1238": "Repression of WNT target genes", "PATHWAY:1239": "Signaling by TCF7L2 mutants", "PATHWAY:1240": "Oleoyl-phe metabolism", "PATHWAY:1241": "Attachment and Entry", "PATHWAY:1242": "Virion Assembly and Release", "PATHWAY:1243": "Maturation of spike protein", "PATHWAY:1244": "Translation of Structural Proteins", "PATHWAY:1245": "Maturation of protein E", "PATHWAY:1246": "SARS-CoV-1 targets PDZ proteins in cell-cell junction", "PATHWAY:1247": "Maturation of protein M", "PATHWAY:1248": "Transcription of SARS-CoV-1 sgRNAs", "PATHWAY:1249": "SARS-CoV-1-host interactions", "PATHWAY:1250": "Replication of the SARS-CoV-1 genome", "PATHWAY:1251": "Assembly of the SARS-CoV-1 Replication-Transcription Complex (RTC)", "PATHWAY:1252": "Maturation of replicase proteins", "PATHWAY:1253": "Interleukin-23 signaling", "PATHWAY:1254": "Regulation of CDH19 Expression and Function", "PATHWAY:1255": "Binding of TCF/LEF:CTNNB1 to target gene promoters", "PATHWAY:1256": "InlA-mediated entry of Listeria monocytogenes into host cells", "PATHWAY:1257": "RUNX3 regulates WNT signaling", "PATHWAY:1258": "Adrenaline signalling through Alpha-2 adrenergic receptor", "PATHWAY:1259": "Uptake of dietary cobalamins into enterocytes", "PATHWAY:1260": "Interleukin-1 processing", "PATHWAY:1261": "Suppression of apoptosis", "PATHWAY:1262": "Endosomal/Vacuolar pathway", "PATHWAY:1263": "Pyrimidine salvage", "PATHWAY:1264": "Pyrimidine catabolism", "PATHWAY:1265": "Regulation of T cell activation by CD28 family", "PATHWAY:1266": "betaKlotho-mediated ligand binding", "PATHWAY:1267": "Phospholipase C-mediated cascade; FGFR4", "PATHWAY:1268": "SHC-mediated cascade:FGFR4", "PATHWAY:1269": "Proton-coupled neutral amino acid transporters", "PATHWAY:1270": "Defective SLC36A2 causes iminoglycinuria (IG) and hyperglycinuria (HG)", "PATHWAY:1271": "Cross-presentation of particulate exogenous antigens (phagosomes)", "PATHWAY:1272": "The activation of arylsulfatases", "PATHWAY:1273": "Negative regulators of DDX58/IFIH1 signaling", "PATHWAY:1274": "Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)", "PATHWAY:1275": "Biosynthesis of protectins", "PATHWAY:1276": "Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2", "PATHWAY:1277": "Biosynthesis of maresin-like SPMs", "PATHWAY:1278": "Defective CYP1B1 causes Glaucoma", "PATHWAY:1279": "CYP2E1 reactions", "PATHWAY:1280": "Metabolism of vitamin K", "PATHWAY:1281": "Uncoating of the HIV Virion", "PATHWAY:1282": "Early Phase of HIV Life Cycle", "PATHWAY:1283": "Minus-strand DNA synthesis", "PATHWAY:1284": "Plus-strand DNA synthesis", "PATHWAY:1285": "Synthesis And Processing Of GAG, GAGPOL Polyproteins", "PATHWAY:1286": "Assembly Of The HIV Virion", "PATHWAY:1287": "Alpha-defensins", "PATHWAY:1288": "Synthesis and processing of ENV and VPU", "PATHWAY:1289": "Calmodulin induced events", "PATHWAY:1290": "Late Phase of HIV Life Cycle", "PATHWAY:1291": "Nef and signal transduction", "PATHWAY:1292": "Prednisone ADME", "PATHWAY:1293": "Sterols are 12-hydroxylated by CYP8B1", "PATHWAY:1294": "Glucocorticoid biosynthesis", "PATHWAY:1295": "Defective CYP11B1 causes AH4", "PATHWAY:1296": "Defective CYP11B2 causes CMO-1 deficiency", "PATHWAY:1297": "Arachidonate metabolism", "PATHWAY:1298": "Defective CYP17A1 causes AH5", "PATHWAY:1299": "Estrogen biosynthesis", "PATHWAY:1300": "Defective CYP19A1 causes AEXS", "PATHWAY:1301": "Wax biosynthesis", "PATHWAY:1302": "Defective CYP21A2 causes AH3", "PATHWAY:1303": "Defective CYP24A1 causes HCAI", "PATHWAY:1304": "Defective CYP27A1 causes CTX", "PATHWAY:1305": "Defective CYP27B1 causes VDDR1A", "PATHWAY:1306": "Reelin signalling pathway", "PATHWAY:1307": "Pyruvate metabolism", "PATHWAY:1308": "Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3", "PATHWAY:1309": "Caspase activation via Dependence Receptors in the absence of ligand", "PATHWAY:1310": "Selenoamino acid metabolism", "PATHWAY:1311": "Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations", "PATHWAY:1312": "Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations", "PATHWAY:1313": "FGFRL1 modulation of FGFR1 signaling", "PATHWAY:1314": "RAS signaling downstream of NF1 loss-of-function variants", "PATHWAY:1315": "Catecholamine biosynthesis", "PATHWAY:1316": "DCC mediated attractive signaling", "PATHWAY:1317": "Role of second messengers in netrin-1 signaling", "PATHWAY:1318": "Regulation of commissural axon pathfinding by SLIT and ROBO", "PATHWAY:1319": "mitochondrial fatty acid beta-oxidation of unsaturated fatty acids", "PATHWAY:1320": "Lysosphingolipid and LPA receptors", "PATHWAY:1321": "Melanin biosynthesis", "PATHWAY:1322": "ATF6 (ATF6-alpha) activates chaperone genes", "PATHWAY:1323": "Advanced glycosylation endproduct receptor signaling", "PATHWAY:1324": "Eicosanoid ligand-binding receptors", "PATHWAY:1325": "Replication of the SARS-CoV-2 genome", "PATHWAY:1326": "DEx/H-box helicases activate type I IFN and inflammatory cytokines production ", "PATHWAY:1327": "Defective MMAA causes MMA, cblA type", "PATHWAY:1328": "Defective MUT causes MMAM", "PATHWAY:1329": "Propionyl-CoA catabolism", "PATHWAY:1330": "Cobalamin (Cbl) metabolism", "PATHWAY:1331": "Striated Muscle Contraction", "PATHWAY:1332": "Alternative complement activation", "PATHWAY:1333": "Apoptosis induced DNA fragmentation", "PATHWAY:1334": "Release of apoptotic factors from the mitochondria", "PATHWAY:1335": "Zinc efflux and compartmentalization by the SLC30 family", "PATHWAY:1336": "Neurotransmitter receptors and postsynaptic signal transmission", "PATHWAY:1337": "Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation", "PATHWAY:1338": "Pyrimidine biosynthesis", "PATHWAY:1339": "Hypusine synthesis from eIF5A-lysine", "PATHWAY:1340": "Regulation of thyroid hormone activity", "PATHWAY:1341": "Regulation of pyruvate dehydrogenase (PDH) complex", "PATHWAY:1342": "Glycine degradation", "PATHWAY:1343": "Unblocking of NMDA receptors, glutamate binding and activation", "PATHWAY:1344": "Ras activation upon Ca2+ influx through NMDA receptor", "PATHWAY:1345": "NrCAM interactions", "PATHWAY:1346": "Activation of Ca-permeable Kainate Receptor", "PATHWAY:1347": "Negative regulation of NMDA receptor-mediated neuronal transmission", "PATHWAY:1348": "Long-term potentiation", "PATHWAY:1349": "Choline catabolism", "PATHWAY:1350": "Transcriptional regulation of testis differentiation", "PATHWAY:1351": "Glycogen breakdown (glycogenolysis)", "PATHWAY:1352": "NTRK2 activates RAC1", "PATHWAY:1353": "Defective DPAGT1 causes CDG-1j, CMSTA2", "PATHWAY:1354": "Degradation of GABA", "PATHWAY:1355": "Defective SLC26A3 causes congenital secretory chloride diarrhea 1 (DIAR1)", "PATHWAY:1356": "Dopamine receptors", "PATHWAY:1357": "Defective SLC26A2 causes chondrodysplasias", "PATHWAY:1358": "GRB2 events in EGFR signaling", "PATHWAY:1359": "SHC1 events in EGFR signaling", "PATHWAY:1360": "EGFR interacts with phospholipase C-gamma", "PATHWAY:1361": "EGFR Transactivation by Gastrin", "PATHWAY:1362": "Uptake and function of diphtheria toxin", "PATHWAY:1363": "Inhibition of Signaling by Overexpressed EGFR", "PATHWAY:1364": "ERKs are inactivated", "PATHWAY:1365": "PCP/CE pathway", "PATHWAY:1366": "Negative regulation of TCF-dependent signaling by DVL-interacting proteins", "PATHWAY:1367": "Activation of NOXA and translocation to mitochondria", "PATHWAY:1368": "Inhibition of replication initiation of damaged DNA by RB1/E2F1", "PATHWAY:1369": "Activation of PUMA and translocation to mitochondria", "PATHWAY:1370": "Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA", "PATHWAY:1371": "Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA", "PATHWAY:1372": "Beta oxidation of octanoyl-CoA to hexanoyl-CoA", "PATHWAY:1373": "Beta oxidation of hexanoyl-CoA to butanoyl-CoA", "PATHWAY:1374": "Defective ABCA1 causes TGD", "PATHWAY:1375": "HDL assembly", "PATHWAY:1376": "Sulfur amino acid metabolism", "PATHWAY:1377": "Defective AHCY causes HMAHCHD", "PATHWAY:1378": "Eukaryotic Translation Elongation", "PATHWAY:1379": "Trafficking of myristoylated proteins to the cilium", "PATHWAY:1380": "Small interfering RNA (siRNA) biogenesis", "PATHWAY:1381": "Post-transcriptional silencing by small RNAs", "PATHWAY:1382": "Regulation of PTEN mRNA translation", "PATHWAY:1383": "Competing endogenous RNAs (ceRNAs) regulate PTEN translation", "PATHWAY:1384": "Transcriptional Regulation by MECP2", "PATHWAY:1385": "Regulation of NPAS4 mRNA translation", "PATHWAY:1386": "EPH-Ephrin signaling", "PATHWAY:1387": "PLCG1 events in ERBB2 signaling", "PATHWAY:1388": "PERK regulates gene expression", "PATHWAY:1389": "Recycling of eIF2:GDP", "PATHWAY:1390": "PAOs oxidise polyamines to amines", "PATHWAY:1391": "Interconversion of polyamines", "PATHWAY:1392": "GDP-fucose biosynthesis", "PATHWAY:1393": "Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S", "PATHWAY:1394": "HuR (ELAVL1) binds and stabilizes mRNA", "PATHWAY:1395": "RUNX1 regulates transcription of genes involved in BCR signaling", "PATHWAY:1396": "RUNX1 regulates transcription of genes involved in interleukin signaling", "PATHWAY:1397": "Defective ALG14 causes ALG14-CMS", "PATHWAY:1398": "Intrinsic Pathway of Fibrin Clot Formation", "PATHWAY:1399": "TET1,2,3 and TDG demethylate DNA", "PATHWAY:1400": "Synthesis of PIPs at the Golgi membrane", "PATHWAY:1401": "Synthesis of PIPs at the early endosome membrane", "PATHWAY:1402": "Synthesis of PIPs at the late endosome membrane", "PATHWAY:1403": "RUNX1 regulates estrogen receptor mediated transcription", "PATHWAY:1404": "ARL13B-mediated ciliary trafficking of INPP5E", "PATHWAY:1405": "GABA receptor activation", "PATHWAY:1406": "Nuclear Envelope Breakdown", "PATHWAY:1407": "Initiation of Nuclear Envelope (NE) Reformation", "PATHWAY:1408": "Depolymerization of the Nuclear Lamina", "PATHWAY:1409": "OAS antiviral response", "PATHWAY:1410": "Manipulation of host energy metabolism", "PATHWAY:1411": "Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane", "PATHWAY:1412": "PI5P Regulates TP53 Acetylation", "PATHWAY:1413": "RUNX3 regulates p14-ARF", "PATHWAY:1414": "STAT3 nuclear events downstream of ALK signaling", "PATHWAY:1415": "Cellular response to hypoxia", "PATHWAY:1416": "Transcriptional regulation of pluripotent stem cells", "PATHWAY:1417": "PTK6 Expression", "PATHWAY:1418": "Pexophagy", "PATHWAY:1419": "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation", "PATHWAY:1420": "Biosynthesis of maresins", "PATHWAY:1421": "SUMO is proteolytically processed", "PATHWAY:1422": "Signaling by Erythropoietin", "PATHWAY:1423": "Erythropoietin activates Phosphoinositide-3-kinase (PI3K)", "PATHWAY:1424": "Erythropoietin activates Phospholipase C gamma (PLCG)", "PATHWAY:1425": "Erythropoietin activates STAT5", "PATHWAY:1426": "GRB7 events in ERBB2 signaling", "PATHWAY:1427": "PDE3B signalling", "PATHWAY:1428": "Inhibition of TSC complex formation by PKB", "PATHWAY:1429": "IRE1alpha activates chaperones", "PATHWAY:1430": "RUNX1 regulates transcription of genes involved in WNT signaling", "PATHWAY:1431": "Defective ABCA3 causes SMDP3", "PATHWAY:1432": "Defective ABCA3 causes SMDP3", "PATHWAY:1433": "Signaling by membrane-tethered fusions of PDGFRA or PDGFRB", "PATHWAY:1434": "Scavenging of heme from plasma", "PATHWAY:1435": "Ciprofloxacin ADME", "PATHWAY:1436": "Gamma-carboxylation of protein precursors", "PATHWAY:1437": "Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus", "PATHWAY:1438": "Removal of aminoterminal propeptides from gamma-carboxylated proteins", "PATHWAY:1439": "Defective factor XII causes hereditary angioedema", "PATHWAY:1440": "Defective F8 cleavage by thrombin", "PATHWAY:1441": "Linoleic acid (LA) metabolism", "PATHWAY:1442": "Defective ABCD1 causes ALD", "PATHWAY:1443": "Extrinsic Pathway of Fibrin Clot Formation", "PATHWAY:1444": "Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation", "PATHWAY:1445": "Defective factor IX causes thrombophilia", "PATHWAY:1446": "Defective F8 accelerates dissociation of the A2 domain", "PATHWAY:1447": "Defective F8 binding to von Willebrand factor", "PATHWAY:1448": "Defective F8 binding to the cell membrane", "PATHWAY:1449": "Defective cofactor function of FVIIIa variant", "PATHWAY:1450": "Defective F8 secretion", "PATHWAY:1451": "Defective F9 variant does not activate FX", "PATHWAY:1452": "Defective F8 sulfation at Y1699", "PATHWAY:1453": "Defective F9 secretion", "PATHWAY:1454": "Defective F9 activation", "PATHWAY:1455": "Defective gamma-carboxylation of F9", "PATHWAY:1456": "Defective SERPING1 causes hereditary angioedema", "PATHWAY:1457": "Metabolism of serotonin", "PATHWAY:1458": "Intracellular metabolism of fatty acids regulates insulin secretion", "PATHWAY:1459": "Tyrosine catabolism", "PATHWAY:1460": "Interleukin-2 signaling", "PATHWAY:1461": "Vitamin B5 (pantothenate) metabolism", "PATHWAY:1462": "TYSND1 cleaves peroxisomal proteins", "PATHWAY:1463": "TGF-beta receptor signaling activates SMADs", "PATHWAY:1464": "Fc epsilon receptor (FCERI) signaling", "PATHWAY:1465": "Role of LAT2/NTAL/LAB on calcium mobilization", "PATHWAY:1466": "FCGR activation", "PATHWAY:1467": "5-Phosphoribose 1-diphosphate biosynthesis", "PATHWAY:1468": "SDK interactions", "PATHWAY:1469": "Biosynthesis of A2E, implicated in retinal degradation", "PATHWAY:1470": "Class C/3 (Metabotropic glutamate/pheromone receptors)", "PATHWAY:1471": "Regulation of gene expression in beta cells", "PATHWAY:1472": "Carnitine synthesis", "PATHWAY:1473": "GRB2:SOS provides linkage to MAPK signaling for Integrins ", "PATHWAY:1474": "Signaling by activated point mutants of FGFR1", "PATHWAY:1475": "Signaling by activated point mutants of FGFR3", "PATHWAY:1476": "FGFR4 ligand binding and activation", "PATHWAY:1477": "FGFR1b ligand binding and activation", "PATHWAY:1478": "FGFR3b ligand binding and activation", "PATHWAY:1479": "FGFR3c ligand binding and activation", "PATHWAY:1480": "FGFR1c ligand binding and activation", "PATHWAY:1481": "FGFR2c ligand binding and activation", "PATHWAY:1482": "Activated point mutants of FGFR2", "PATHWAY:1483": "Phospholipase C-mediated cascade: FGFR1", "PATHWAY:1484": "Phospholipase C-mediated cascade; FGFR2", "PATHWAY:1485": "Phospholipase C-mediated cascade; FGFR3", "PATHWAY:1486": "Downstream signaling of activated FGFR1", "PATHWAY:1487": "SHC-mediated cascade:FGFR1", "PATHWAY:1488": "SHC-mediated cascade:FGFR2", "PATHWAY:1489": "SHC-mediated cascade:FGFR3", "PATHWAY:1490": "Signaling by FGFR2 IIIa TM", "PATHWAY:1491": "Formation of intermediate mesoderm", "PATHWAY:1492": "Regulation of gene expression in early pancreatic precursor cells", "PATHWAY:1493": "Signaling by FGFR1 amplification mutants", "PATHWAY:1494": "FGFR1c and Klotho ligand binding and activation", "PATHWAY:1495": "Epithelial-Mesenchymal Transition (EMT) during gastrulation", "PATHWAY:1496": "t(4;14) translocations of FGFR3", "PATHWAY:1497": "Signaling by FGFR3 fusions in cancer", "PATHWAY:1498": "Signaling by FGFR2 amplification mutants", "PATHWAY:1499": "Signaling by FGFR2 fusions", "PATHWAY:1500": "FGFR4 mutant receptor activation", "PATHWAY:1501": "VEGF ligand-receptor interactions", "PATHWAY:1502": "VEGF binds to VEGFR leading to receptor dimerization", "PATHWAY:1503": "Calcineurin activates NFAT", "PATHWAY:1504": "TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)", "PATHWAY:1505": "TGFBR1 LBD Mutants in Cancer", "PATHWAY:1506": "RAF activation", "PATHWAY:1507": "SHOC2 M1731 mutant abolishes MRAS complex function", "PATHWAY:1508": "Gain-of-function MRAS complexes activate RAF signaling", "PATHWAY:1509": "Interaction between PHLDA1 and AURKA", "PATHWAY:1510": "Defective DOLK causes DOLK-CDG", "PATHWAY:1511": "The NLRP1 inflammasome", "PATHWAY:1512": "Hereditary fructose intolerance", "PATHWAY:1513": "Formation of apoptosome", "PATHWAY:1514": "Regulation of the apoptosome activity", "PATHWAY:1515": "RHOT2 GTPase cycle", "PATHWAY:1516": "RHOT1 GTPase cycle", "PATHWAY:1517": "Synthesis of PIPs at the ER membrane", "PATHWAY:1518": "Abortive elongation of HIV-1 transcript in the absence of Tat", "PATHWAY:1519": "FGFR2 alternative splicing", "PATHWAY:1520": "Protein repair", "PATHWAY:1521": "ATF6 (ATF6-alpha) activates chaperones", "PATHWAY:1522": "RPIA deficiency: failed conversion of R5P to RU5P", "PATHWAY:1523": "RPIA deficiency: failed conversion of RU5P to R5P", "PATHWAY:1524": "Pentose phosphate pathway", "PATHWAY:1525": "Formation of lateral plate mesoderm", "PATHWAY:1526": "Regulation of CDH11 gene transcription", "PATHWAY:1527": "Signaling by LRP5 mutants ", "PATHWAY:1528": "Biosynthesis of Lipoxins (LX)", "PATHWAY:1529": "Elevation of cytosolic Ca2+ levels", "PATHWAY:1530": "Platelet homeostasis", "PATHWAY:1531": "Toxicity of botulinum toxin type D (botD)", "PATHWAY:1532": "Toxicity of botulinum toxin type A (botA)", "PATHWAY:1533": "Toxicity of botulinum toxin type F (botF)", "PATHWAY:1534": "Fructose biosynthesis", "PATHWAY:1535": "Scavenging by Class H Receptors", "PATHWAY:1536": "Formation of the active cofactor, UDP-glucuronate", "PATHWAY:1537": "Defective SLC35D1 causes SCHBCKD", "PATHWAY:1538": "N-glycan trimming in the ER and Calnexin/Calreticulin cycle", "PATHWAY:1539": "Calnexin/calreticulin cycle", "PATHWAY:1540": "Neurophilin interactions with VEGF and VEGFR", "PATHWAY:1541": "STAT5 Activation", "PATHWAY:1542": "FLT3 mutants bind TKIs", "PATHWAY:1543": "KW2449-resistant FLT3 mutants", "PATHWAY:1544": "semaxanib-resistant FLT3 mutants", "PATHWAY:1545": "crenolanib-resistant FLT3 mutants", "PATHWAY:1546": "gilteritinib-resistant FLT3 mutants", "PATHWAY:1547": "lestaurtinib-resistant FLT3 mutants", "PATHWAY:1548": "midostaurin-resistant FLT3 mutants", "PATHWAY:1549": "pexidartinib-resistant FLT3 mutants", "PATHWAY:1550": "ponatinib-resistant FLT3 mutants", "PATHWAY:1551": "quizartinib-resistant FLT3 mutants", "PATHWAY:1552": "sorafenib-resistant FLT3 mutants", "PATHWAY:1553": "sunitinib-resistant FLT3 mutants", "PATHWAY:1554": "tandutinib-resistant FLT3 mutants", "PATHWAY:1555": "linifanib-resistant FLT3 mutants", "PATHWAY:1556": "tamatinib-resistant FLT3 mutants", "PATHWAY:1557": "Signaling by FLT3 ITD and TKD mutants", "PATHWAY:1558": "FLT3 signaling through SRC family kinases", "PATHWAY:1559": "FLT3 signaling by CBL mutants", "PATHWAY:1560": "Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion", "PATHWAY:1561": "FMO oxidises nucleophiles", "PATHWAY:1562": "Defective FMO3 causes TMAU", "PATHWAY:1563": "Lysosomal oligosaccharide catabolism", "PATHWAY:1564": "Inactivation of CDC42 and RAC1", "PATHWAY:1565": "Bicarbonate transporters", "PATHWAY:1566": "Regulated proteolysis of p75NTR", "PATHWAY:1567": "NRIF signals cell death from the nucleus", "PATHWAY:1568": "Noncanonical activation of NOTCH3", "PATHWAY:1569": "tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis", "PATHWAY:1570": "Defective SLC35A3 causes arthrogryposis, mental retardation, and seizures (AMRS)", "PATHWAY:1571": "Maturation of replicase proteins", "PATHWAY:1572": "Pre-NOTCH Processing in the Endoplasmic Reticulum", "PATHWAY:1573": "Zinc influx into cells by the SLC39 gene family", "PATHWAY:1574": "Formation of Senescence-Associated Heterochromatin Foci (SAHF)", "PATHWAY:1575": "Synthesis of glycosylphosphatidylinositol (GPI)", "PATHWAY:1576": "Formyl peptide receptors bind formyl peptides and many other ligands", "PATHWAY:1577": "Displacement of DNA glycosylase by APEX1", "PATHWAY:1578": "DDX58/IFIH1-mediated induction of interferon-alpha/beta", "PATHWAY:1579": "E2F-enabled inhibition of pre-replication complex formation", "PATHWAY:1580": "CDC6 association with the ORC:origin complex", "PATHWAY:1581": "Nephrin family interactions", "PATHWAY:1582": "DNA replication initiation", "PATHWAY:1583": "Nectin/Necl  trans heterodimerization", "PATHWAY:1584": "PI and PC transport between ER and Golgi membranes", "PATHWAY:1585": "Signaling by ROBO receptors", "PATHWAY:1586": "ASP-3026-resistant ALK mutants", "PATHWAY:1587": "NVP-TAE684-resistant ALK mutants", "PATHWAY:1588": "alectinib-resistant ALK mutants", "PATHWAY:1589": "brigatinib-resistant ALK mutants", "PATHWAY:1590": "ceritinib-resistant ALK mutants", "PATHWAY:1591": "crizotinib-resistant ALK mutants", "PATHWAY:1592": "lorlatinib-resistant ALK mutants", "PATHWAY:1593": "Synthesis of Hepoxilins (HX) and Trioxilins (TrX)", "PATHWAY:1594": "Synthesis of 12-eicosatetraenoic acid derivatives", "PATHWAY:1595": "Biosynthesis of DHA-derived SPMs", "PATHWAY:1596": "Biosynthesis of DPAn-6 SPMs", "PATHWAY:1597": "Biosynthesis of DPAn-3-derived maresins", "PATHWAY:1598": "Synthesis of 5-eicosatetraenoic acids", "PATHWAY:1599": "Biosynthesis of D-series resolvins", "PATHWAY:1600": "Biosynthesis of E-series 18(S)-resolvins", "PATHWAY:1601": "Biosynthesis of aspirin-triggered D-series resolvins", "PATHWAY:1602": "Biosynthesis of E-series 18(R)-resolvins", "PATHWAY:1603": "Biosynthesis of DPAn-3-derived protectins and resolvins", "PATHWAY:1604": "Biosynthesis of DPAn-3-derived 13-series resolvins", "PATHWAY:1605": "Biosynthesis of electrophilic \u03c9-3 PUFA oxo-derivatives", "PATHWAY:1606": "Toxicity of tetanus toxin (tetX)", "PATHWAY:1607": "Synthesis of 15-eicosatetraenoic acid derivatives", "PATHWAY:1608": "Defective SLC17A8 causes autosomal dominant deafness 25 (DFNA25)", "PATHWAY:1609": "Digestion", "PATHWAY:1610": "ABO blood group biosynthesis", "PATHWAY:1611": "Generation of second messenger molecules", "PATHWAY:1612": "PECAM1 interactions", "PATHWAY:1613": "Co-stimulation by CD28", "PATHWAY:1614": "CD28 dependent Vav1 pathway", "PATHWAY:1615": "Activated NTRK2 signals through FYN", "PATHWAY:1616": "Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants", "PATHWAY:1617": "Synthesis of IPs in the nucleus", "PATHWAY:1618": "Acyl chain remodeling of CL", "PATHWAY:1619": "Glycogen storage disease type Ia (G6PC)", "PATHWAY:1620": "Glycogen storage disease type Ib (SLC37A4)", "PATHWAY:1621": "Glycogen storage disease type II (GAA)", "PATHWAY:1622": "MET activates PI3K/AKT signaling", "PATHWAY:1623": "MET activates PTPN11", "PATHWAY:1624": "Activated NTRK2 signals through PI3K", "PATHWAY:1625": "GABA B receptor activation", "PATHWAY:1626": "Synthesis of dolichyl-phosphate-glucose", "PATHWAY:1627": "GABA synthesis", "PATHWAY:1628": "MECP2 regulates transcription of genes involved in GABA signaling", "PATHWAY:1629": "Signalling to RAS", "PATHWAY:1630": "Defective GALE causes EDG", "PATHWAY:1631": "Galactose catabolism", "PATHWAY:1632": "tRNA modification in the mitochondrion", "PATHWAY:1633": "Defective GALK1 causes GALCT2", "PATHWAY:1634": "MPS IV - Morquio syndrome A", "PATHWAY:1635": "Translesion Synthesis by POLH", "PATHWAY:1636": "Defective GALT can cause GALCT", "PATHWAY:1637": "NTRK3 as a dependence receptor", "PATHWAY:1638": "Phenylalanine metabolism", "PATHWAY:1639": "Nucleotide catabolism", "PATHWAY:1640": "Loss of MECP2 binding ability to 5mC-DNA", "PATHWAY:1641": "Signaling by Leptin", "PATHWAY:1642": "Defective MMADHC causes MMAHCD", "PATHWAY:1643": "Defective MMACHC causes MAHCC", "PATHWAY:1644": "Plasmalogen biosynthesis", "PATHWAY:1645": "Golgi Cisternae Pericentriolar Stack Reorganization", "PATHWAY:1646": "Chylomicron clearance", "PATHWAY:1647": "Transport of RCbl within the body", "PATHWAY:1648": "Defective ABCA12 causes ARCI4B", "PATHWAY:1649": "Ligand-receptor interactions", "PATHWAY:1650": "Translocation of ZAP-70 to Immunological synapse", "PATHWAY:1651": "Metabolism of polyamines", "PATHWAY:1652": "Sodium-coupled sulphate, di- and tri-carboxylate transporters", "PATHWAY:1653": "Phosphorylation of Emi1", "PATHWAY:1654": "Mitotic Metaphase/Anaphase Transition", "PATHWAY:1655": "Glycogen synthesis", "PATHWAY:1656": "Glycogen storage disease type IV (GBE1)", "PATHWAY:1657": "Defective GCK causes maturity-onset diabetes of the young 2 (MODY2)", "PATHWAY:1658": "Defective SLC17A5 causes Salla disease (SD) and ISSD", "PATHWAY:1659": "Interleukin-36 pathway", "PATHWAY:1660": "Defective GFPT1 causes CMSTA1", "PATHWAY:1661": "Synthesis of UDP-N-acetyl-glucosamine", "PATHWAY:1662": "Defective GGT1 causes GLUTH", "PATHWAY:1663": "Defective GGT1 in aflatoxin detoxification causes GLUTH", "PATHWAY:1664": "Defective B4GALT1 causes CDG-2d", "PATHWAY:1665": "Lactose synthesis", "PATHWAY:1666": "Defective OPLAH causes OPLAHD", "PATHWAY:1667": "Defective CBLIF causes IFD", "PATHWAY:1668": "Defective AMN causes MGA1", "PATHWAY:1669": "Defective CUBN causes MGA1", "PATHWAY:1670": "Oligomerization of connexins into connexons", "PATHWAY:1671": "Transport of connexins along the secretory pathway", "PATHWAY:1672": "Regulation of gap junction activity", "PATHWAY:1673": "SARS-CoV-2 targets PDZ proteins in cell-cell junction", "PATHWAY:1674": "NADE modulates death signalling", "PATHWAY:1675": "Transport of connexons to the plasma membrane", "PATHWAY:1676": "Pyrophosphate hydrolysis", "PATHWAY:1677": "Synthesis of IP2, IP, and Ins in the cytosol", "PATHWAY:1678": "Glycerophospholipid biosynthesis", "PATHWAY:1679": "Neurotransmitter release cycle", "PATHWAY:1680": "Glutamate and glutamine metabolism", "PATHWAY:1681": "Hydroxycarboxylic acid-binding receptors", "PATHWAY:1682": "MPS IV - Morquio syndrome B", "PATHWAY:1683": "Defective NEU1 causes sialidosis", "PATHWAY:1684": "Defective GCLC causes HAGGSD", "PATHWAY:1685": "RSK activation", "PATHWAY:1686": "GLI proteins bind promoters of Hh responsive genes to promote transcription", "PATHWAY:1687": "RUNX2 regulates chondrocyte maturation", "PATHWAY:1688": "Astrocytic Glutamate-Glutamine Uptake And Metabolism", "PATHWAY:1689": "MPS IIID - Sanfilippo syndrome D", "PATHWAY:1690": "Methionine salvage pathway", "PATHWAY:1691": "Defective SLCO1B3 causes hyperbilirubinemia, Rotor type (HBLRR)", "PATHWAY:1692": "Passive transport by Aquaporins", "PATHWAY:1693": "Defective SLC24A5 causes oculocutaneous albinism 6 (OCA6)", "PATHWAY:1694": "Peroxisomal lipid metabolism", "PATHWAY:1695": "Tie2 Signaling", "PATHWAY:1696": "Negative regulation of activity of TFAP2 (AP-2) family transcription factors", "PATHWAY:1697": "Scavenging by Class B Receptors", "PATHWAY:1698": "Regulation of FZD by ubiquitination", "PATHWAY:1699": "Defective SLC9A9 causes autism 16 (AUTS16)", "PATHWAY:1700": "Free fatty acid receptors", "PATHWAY:1701": "Loss of MECP2 binding ability to the NCoR/SMRT complex", "PATHWAY:1702": "Alanine metabolism", "PATHWAY:1703": "SOS-mediated signalling", "PATHWAY:1704": "SHC-related events triggered by IGF1R", "PATHWAY:1705": "Signal attenuation", "PATHWAY:1706": "Insulin receptor signalling cascade", "PATHWAY:1707": "Interleukin-15 signaling", "PATHWAY:1708": "Activated NTRK2 signals through RAS", "PATHWAY:1709": "Activated NTRK3 signals through RAS", "PATHWAY:1710": "Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants", "PATHWAY:1711": "Signaling by PDGFRA extracellular domain mutants", "PATHWAY:1712": "IRS activation", "PATHWAY:1713": "Activation of AMPA receptors", "PATHWAY:1714": "Activation of Na-permeable kainate receptors", "PATHWAY:1715": "Regulation of NPAS4 gene transcription", "PATHWAY:1716": "Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization", "PATHWAY:1717": "The AIM2 inflammasome", "PATHWAY:1718": "STAT6-mediated induction of chemokines", "PATHWAY:1719": "Influenza Virus Induced Apoptosis", "PATHWAY:1720": "Metabolism of ingested H2SeO4 and H2SeO3 into H2Se", "PATHWAY:1721": "Defective GSS causes GSS deficiency", "PATHWAY:1722": "Biosynthesis of maresin conjugates in tissue regeneration (MCTR)", "PATHWAY:1723": "Defective Mismatch Repair Associated With MSH2", "PATHWAY:1724": "Defective Mismatch Repair Associated With MSH6", "PATHWAY:1725": "Nitric oxide stimulates guanylate cyclase", "PATHWAY:1726": "Regulation of cytoskeletal remodeling and cell spreading by IPP complex components", "PATHWAY:1727": "Intestinal infectious diseases", "PATHWAY:1728": "Intestinal lipid absorption", "PATHWAY:1729": "MPS VII - Sly syndrome", "PATHWAY:1730": "Myoclonic epilepsy of Lafora", "PATHWAY:1731": "Glycogen storage disease type XV (GYG1)", "PATHWAY:1732": "Glycogen storage disease type 0 (muscle GYS1)", "PATHWAY:1733": "Synthesis of GDP-mannose", "PATHWAY:1734": "Defective ALG6 causes CDG-1c", "PATHWAY:1735": "Glycogen storage disease type 0 (liver GYS2)", "PATHWAY:1736": "Activation, myristolyation of BID and translocation to mitochondria", "PATHWAY:1737": "Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum)", "PATHWAY:1738": "Dissolution of Fibrin Clot", "PATHWAY:1739": "tRNA processing in the mitochondrion", "PATHWAY:1740": "rRNA processing in the mitochondrion", "PATHWAY:1741": "Beta oxidation of myristoyl-CoA to lauroyl-CoA", "PATHWAY:1742": "Beta oxidation of palmitoyl-CoA to myristoyl-CoA", "PATHWAY:1743": "Erythrocytes take up carbon dioxide and release oxygen", "PATHWAY:1744": "Erythrocytes take up oxygen and release carbon dioxide", "PATHWAY:1745": "HDL clearance", "PATHWAY:1746": "Defective HEXA causes GM2G1", "PATHWAY:1747": "Defective HEXB causes GM2G2", "PATHWAY:1748": "Phase 1 - inactivation of fast Na+ channels", "PATHWAY:1749": "MET interacts with TNS proteins", "PATHWAY:1750": "MET activates STAT3", "PATHWAY:1751": "Drug-mediated inhibition of MET activation", "PATHWAY:1752": "Toll Like Receptor 9 (TLR9) Cascade", "PATHWAY:1753": "Defective HK1 causes hexokinase deficiency (HK deficiency)", "PATHWAY:1754": "Biotin transport and metabolism", "PATHWAY:1755": "Defective HLCS causes multiple carboxylase deficiency", "PATHWAY:1756": "Synthesis of Ketone Bodies", "PATHWAY:1757": "Vitamin B6 activation to pyridoxal phosphate", "PATHWAY:1758": "Regulation of HMOX1 expression and activity", "PATHWAY:1759": "Activation of caspases through apoptosome-mediated cleavage", "PATHWAY:1760": "SMAC (DIABLO) binds to IAPs ", "PATHWAY:1761": "SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes ", "PATHWAY:1762": "TP53 Regulates Transcription of Caspase Activators and Caspases", "PATHWAY:1763": "APC truncation mutants are not K63 polyubiquitinated", "PATHWAY:1764": "Defective HPRT1 disrupts guanine and hypoxanthine salvage", "PATHWAY:1765": "Estrogen-stimulated signaling through PRKCZ", "PATHWAY:1766": "Signaling by RAS GAP mutants", "PATHWAY:1767": "Signaling by RAS GTPase mutants", "PATHWAY:1768": "Defective MMAB causes MMA, cblB type", "PATHWAY:1769": "Resolution of AP sites via the multiple-nucleotide patch replacement pathway", "PATHWAY:1770": "Abasic sugar-phosphate removal via the single-nucleotide replacement pathway", "PATHWAY:1771": "Resolution of Abasic Sites (AP sites)", "PATHWAY:1772": "Viral RNP Complexes in the Host Cell Nucleus", "PATHWAY:1773": "ATF6B (ATF6-beta) activates chaperones", "PATHWAY:1774": "SMAC, XIAP-regulated apoptotic response", "PATHWAY:1775": "Regulation of PTEN localization", "PATHWAY:1776": "vRNP Assembly", "PATHWAY:1777": "TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation", "PATHWAY:1778": "Chylomicron assembly", "PATHWAY:1779": "Serotonin receptors", "PATHWAY:1780": "MPS IX - Natowicz syndrome", "PATHWAY:1781": "VLDL assembly", "PATHWAY:1782": "VLDL clearance", "PATHWAY:1783": "Metal sequestration by antimicrobial proteins", "PATHWAY:1784": "TWIK-related spinal cord K+ channel (TRESK)", "PATHWAY:1785": "Defective SLC6A19 causes Hartnup disorder (HND)", "PATHWAY:1786": "Defective SLC6A19 causes Hartnup disorder (HND)", "PATHWAY:1787": "Defective CYP26C1 causes FFDD4", "PATHWAY:1788": "Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate", "PATHWAY:1789": "NADPH regeneration", "PATHWAY:1790": "NFE2L2 regulating TCA cycle genes", "PATHWAY:1791": "MPS II - Hunter syndrome", "PATHWAY:1792": "MPS I - Hurler syndrome", "PATHWAY:1793": "Regulation of IFNG signaling", "PATHWAY:1794": "IFNG signaling activates MAPKs", "PATHWAY:1795": "Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)", "PATHWAY:1796": "IRS-related events triggered by IGF1R", "PATHWAY:1797": "Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors", "PATHWAY:1798": "Defective SLC6A18 may confer susceptibility to iminoglycinuria and/or hyperglycinuria", "PATHWAY:1799": "Defective SLC6A18 may confer susceptibility to iminoglycinuria and/or hyperglycinuria", "PATHWAY:1800": "Defective APRT disrupts adenine salvage", "PATHWAY:1801": "HHAT G278V doesn't palmitoylate Hh-Np", "PATHWAY:1802": "Regulation by c-FLIP", "PATHWAY:1803": "CASP8 activity is inhibited", "PATHWAY:1804": "Dimerization of procaspase-8", "PATHWAY:1805": "FasL/ CD95L signaling", "PATHWAY:1806": "p75NTR recruits signalling complexes", "PATHWAY:1807": "NF-kB is activated and signals survival", "PATHWAY:1808": "Interleukin-33 signaling", "PATHWAY:1809": "Interleukin-9 signaling", "PATHWAY:1810": "Interleukin-21 signaling", "PATHWAY:1811": "Interleukin-6 signaling", "PATHWAY:1812": "MAPK3 (ERK1) activation", "PATHWAY:1813": "MAPK1 (ERK2) activation", "PATHWAY:1814": "Interleukin-12 signaling", "PATHWAY:1815": "Localization of the PINCH-ILK-PARVIN complex to focal adhesions", "PATHWAY:1816": "Signaling by Insulin receptor", "PATHWAY:1817": "Transport of glycerol from adipocytes to the liver by Aquaporins", "PATHWAY:1818": "Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells", "PATHWAY:1819": "TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling", "PATHWAY:1820": "TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation", "PATHWAY:1821": "MyD88 dependent cascade initiated on endosome", "PATHWAY:1822": "MyD88 cascade initiated on plasma membrane", "PATHWAY:1823": "IRS-mediated signalling", "PATHWAY:1824": "PI3K/AKT activation", "PATHWAY:1825": "Activated NTRK3 signals through PI3K", "PATHWAY:1826": "RUNX3 Regulates Immune Response and Cell Migration", "PATHWAY:1827": "Defective ABCC6 causes PXE", "PATHWAY:1828": "trans-Golgi Network Vesicle Budding", "PATHWAY:1829": "Potassium transport channels", "PATHWAY:1830": "Classical Kir channels", "PATHWAY:1831": "Defective ABCC8 can cause hypo- and hyper-glycemias", "PATHWAY:1832": "TWIK related potassium channel (TREK)", "PATHWAY:1833": "TWIK-releated acid-sensitive K+ channel (TASK)", "PATHWAY:1834": "Acetylcholine inhibits contraction of outer hair cells", "PATHWAY:1835": "Phosphate bond hydrolysis by NTPDase proteins", "PATHWAY:1836": "Essential fructosuria", "PATHWAY:1837": "Utilization of Ketone Bodies", "PATHWAY:1838": "Dasatinib-resistant KIT mutants", "PATHWAY:1839": "Imatinib-resistant KIT mutants", "PATHWAY:1840": "KIT mutants bind TKIs", "PATHWAY:1841": "Masitinib-resistant KIT mutants", "PATHWAY:1842": "Nilotinib-resistant KIT mutants", "PATHWAY:1843": "Regorafenib-resistant KIT mutants", "PATHWAY:1844": "Signaling by kinase domain mutants of KIT", "PATHWAY:1845": "Sunitinib-resistant KIT mutants", "PATHWAY:1846": "Signaling by juxtamembrane domain KIT mutants", "PATHWAY:1847": "Sorafenib-resistant KIT mutants", "PATHWAY:1848": "Signaling by extracellular domain mutants of KIT", "PATHWAY:1849": "Inhibition of nitric oxide production", "PATHWAY:1850": "Axonal growth inhibition (RHOA activation)", "PATHWAY:1851": "Axonal growth stimulation", "PATHWAY:1852": "SLIT2:ROBO1 increases RHOA activity", "PATHWAY:1853": "Transfer of LPS from LBP carrier to CD14", "PATHWAY:1854": "Intestinal saccharidase deficiencies", "PATHWAY:1855": "Defective LFNG causes SCDO3", "PATHWAY:1856": "RUNX2 regulates genes involved in differentiation of myeloid cells", "PATHWAY:1857": "Interleukin-2 family signaling", "PATHWAY:1858": "Resolution of AP sites via the single-nucleotide replacement pathway", "PATHWAY:1859": "Transport to the Golgi and subsequent modification", "PATHWAY:1860": "Breakdown of the nuclear lamina", "PATHWAY:1861": "Events associated with phagocytolytic activity of PMN cells", "PATHWAY:1862": "Signaling by RNF43 mutants", "PATHWAY:1863": "Biosynthesis of protectin and resolvin conjugates in tissue regeneration (PCTR and RCTR)", "PATHWAY:1864": "Mtb iron assimilation by chelation", "PATHWAY:1865": "CD22 mediated BCR regulation", "PATHWAY:1866": "Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components", "PATHWAY:1867": "SMAD2/3 Phosphorylation Motif Mutants in Cancer", "PATHWAY:1868": "SMAD4 MH2 Domain Mutants in Cancer", "PATHWAY:1869": "SMAD2/3 MH2 Domain Mutants in Cancer", "PATHWAY:1870": "TGFBR1 KD Mutants in Cancer", "PATHWAY:1871": "MPS VI - Maroteaux-Lamy syndrome", "PATHWAY:1872": "Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB", "PATHWAY:1873": "Dopamine clearance from the synaptic cleft", "PATHWAY:1874": "Defective MAOA causes BRUNS", "PATHWAY:1875": "Defective MAT1A causes MATD", "PATHWAY:1876": "Defective ACTH causes obesity and POMCD", "PATHWAY:1877": "Unwinding of DNA", "PATHWAY:1878": "Switching of origins to a post-replicative state", "PATHWAY:1879": "Loss of MECP2 binding ability to 5hmC-DNA", "PATHWAY:1880": "Loss of phosphorylation of MECP2 at T308", "PATHWAY:1881": "N-glycan trimming and elongation in the cis-Golgi", "PATHWAY:1882": "Defective MGAT2 causes CDG-2a", "PATHWAY:1883": "Reactions specific to the hybrid N-glycan synthesis pathway", "PATHWAY:1884": "MGMT-mediated DNA damage reversal", "PATHWAY:1885": "Defective Mismatch Repair Associated With MLH1", "PATHWAY:1886": "Defective Mismatch Repair Associated With PMS2", "PATHWAY:1887": "Neurotransmitter clearance", "PATHWAY:1888": "Defective MPI causes MPI-CDG", "PATHWAY:1889": "Modulation by Mtb of host immune system", "PATHWAY:1890": "Virion Assembly and Release", "PATHWAY:1891": "Translation of Structural Proteins", "PATHWAY:1892": "Maturation of protein E", "PATHWAY:1893": "Maturation of protein M", "PATHWAY:1894": "Translation of Accessory Proteins", "PATHWAY:1895": "Transcription of SARS-CoV-2 sgRNAs", "PATHWAY:1896": "Assembly of the SARS-CoV-2 Replication-Transcription Complex (RTC)", "PATHWAY:1897": "Defective ALG11 causes CDG-1p", "PATHWAY:1898": "Defective Mismatch Repair Associated With MSH3", "PATHWAY:1899": "Metallothioneins bind metals", "PATHWAY:1900": "Tolerance by Mtb to nitric oxide produced by macrophages", "PATHWAY:1901": "Inhibition of membrane repair", "PATHWAY:1902": "Cell redox homeostasis", "PATHWAY:1903": "Tolerance of reactive oxygen produced by macrophages", "PATHWAY:1904": "Antimicrobial action and antimicrobial resistance in Mtb", "PATHWAY:1905": "Blockage of phagosome acidification", "PATHWAY:1906": "Defective MTRR causes HMAE", "PATHWAY:1907": "Defective MTR causes HMAG", "PATHWAY:1908": "Defective MUTYH substrate binding", "PATHWAY:1909": "Defective MUTYH substrate processing", "PATHWAY:1910": "Regulation of NFE2L2 gene expression", "PATHWAY:1911": "MyD88 deficiency (TLR5)", "PATHWAY:1912": "IRAK4 deficiency (TLR5)", "PATHWAY:1913": "MPS IIIB - Sanfilippo syndrome B", "PATHWAY:1914": "Ion influx/efflux at host-pathogen interface", "PATHWAY:1915": "PLC-gamma1 signalling", "PATHWAY:1916": "NGF processing", "PATHWAY:1917": "TRKA activation by NGF", "PATHWAY:1918": "Signalling to p38 via RIT and RIN", "PATHWAY:1919": "Ceramide signalling", "PATHWAY:1920": "Signalling to STAT3", "PATHWAY:1921": "NFG and proNGF binds to p75NTR", "PATHWAY:1922": "NOSIP mediated eNOS trafficking", "PATHWAY:1923": "Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling", "PATHWAY:1924": "Defective PNP disrupts phosphorolysis of (deoxy)guanosine and (deoxy)inosine", "PATHWAY:1925": "Reduction of cytosolic Ca++ levels", "PATHWAY:1926": "Defective SLC11A2 causes hypochromic microcytic anemia, with iron overload 1 (AHMIO1)", "PATHWAY:1927": "NTF3 activates NTRK2 (TRKB) signaling", "PATHWAY:1928": "NTF3 activates NTRK3 signaling", "PATHWAY:1929": "Signaling by NTRK3 (TRKC)", "PATHWAY:1930": "Activated NTRK3 signals through PLCG1", "PATHWAY:1931": "NTF4 activates NTRK2 (TRKB) signaling", "PATHWAY:1932": "Activated NTRK2 signals through PLCG1", "PATHWAY:1933": "Defective NTHL1 substrate processing", "PATHWAY:1934": "Defective NTHL1 substrate binding", "PATHWAY:1935": "BDNF activates NTRK2 (TRKB) signaling", "PATHWAY:1936": "Mitotic Prophase", "PATHWAY:1937": "Defective OGG1 Substrate Binding", "PATHWAY:1938": "Defective OGG1 Substrate Processing", "PATHWAY:1939": "Defective OGG1 Localization", "PATHWAY:1940": "Opioid Signalling", "PATHWAY:1941": "Organic cation transport", "PATHWAY:1942": "Defective SLC22A18 causes lung cancer (LNCR) and embryonal rhabdomyosarcoma 1 (RMSE1)", "PATHWAY:1943": "Vasopressin-like receptors", "PATHWAY:1944": "Phenylketonuria", "PATHWAY:1945": "Regulation of PAK-2p34 activity by PS-GAP/RHG10", "PATHWAY:1946": "Stimulation of the cell death response by PAK-2p34", "PATHWAY:1947": "WNT ligand biogenesis and trafficking", "PATHWAY:1948": "PKA-mediated phosphorylation of key metabolic factors", "PATHWAY:1949": "AMPK inhibits chREBP transcriptional activation activity", "PATHWAY:1950": "PP2A-mediated dephosphorylation of key metabolic factors", "PATHWAY:1951": "Essential pentosuria", "PATHWAY:1952": "Peptide hormone biosynthesis", "PATHWAY:1953": "Transport of vitamins, nucleosides, and related molecules", "PATHWAY:1954": "Toll Like Receptor 7/8 (TLR7/8) Cascade", "PATHWAY:1955": "Defective CD320 causes MMATC", "PATHWAY:1956": "Cam-PDE 1 activation", "PATHWAY:1957": "Rhesus glycoproteins mediate ammonium transport", "PATHWAY:1958": "Imatinib-resistant PDGFR mutants", "PATHWAY:1959": "Sunitinib-resistant PDGFR mutants", "PATHWAY:1960": "Regorafenib-resistant PDGFR mutants", "PATHWAY:1961": "Sorafenib-resistant PDGFR mutants", "PATHWAY:1962": "PDGFR mutants bind TKIs", "PATHWAY:1963": "Defective SLC26A4 causes Pendred syndrome (PDS)", "PATHWAY:1964": "Regulation of glycolysis by fructose 2,6-bisphosphate metabolism", "PATHWAY:1965": "Defective PGM1 causes PGM1-CDG", "PATHWAY:1966": "Abacavir transmembrane transport", "PATHWAY:1967": "Defective ABCB4 causes PFIC3, ICP3 and GBD1", "PATHWAY:1968": "Synthesis of PIPs in the nucleus", "PATHWAY:1969": "phospho-PLA2 pathway", "PATHWAY:1970": "Coenzyme A biosynthesis", "PATHWAY:1971": "Defective PMM2 causes PMM2-CDG", "PATHWAY:1972": "Synthesis of dolichyl-phosphate mannose", "PATHWAY:1973": "Defective DPM1 causes DPM1-CDG", "PATHWAY:1974": "Defective DPM3 causes DPM3-CDG", "PATHWAY:1975": "Defective DPM2 causes DPM2-CDG", "PATHWAY:1976": "Mitochondrial transcription initiation", "PATHWAY:1977": "Cytochrome P450 - arranged by substrate type", "PATHWAY:1978": "POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation", "PATHWAY:1979": "Defective UGT1A4 causes hyperbilirubinemia", "PATHWAY:1980": "Defective UGT1A1 causes hyperbilirubinemia", "PATHWAY:1981": "Synthesis of CL", "PATHWAY:1982": "Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG)", "PATHWAY:1983": "Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG)", "PATHWAY:1984": "Reversal of alkylation damage by DNA dioxygenases", "PATHWAY:1985": "Defective AVP does not bind AVPR1A,B and causes neurohypophyseal diabetes insipidus (NDI)", "PATHWAY:1986": "Defective AVP does not bind AVPR2 and causes neurohypophyseal diabetes insipidus (NDI)", "PATHWAY:1987": "Integration of energy metabolism", "PATHWAY:1988": "Defective Base Excision Repair Associated with NEIL3", "PATHWAY:1989": "NEIL3-mediated resolution of ICLs", "PATHWAY:1990": "Defective SLC29A3 causes histiocytosis-lymphadenopathy plus syndrome (HLAS)", "PATHWAY:1991": "ROBO receptors bind AKAP5", "PATHWAY:1992": "Defective SLC35C1 causes congenital disorder of glycosylation 2C (CDG2C)", "PATHWAY:1993": "PTK6 Activates STAT3", "PATHWAY:1994": "Defective SLC39A4 causes acrodermatitis enteropathica, zinc-deficiency type (AEZ)", "PATHWAY:1995": "Disinhibition of SNARE formation", "PATHWAY:1996": "Response to elevated platelet cytosolic Ca2+", "PATHWAY:1997": "Defective ABCD4 causes MAHCJ", "PATHWAY:1998": "Negative feedback regulation of MAPK pathway", "PATHWAY:1999": "Signaling by MAP2K mutants", "PATHWAY:2000": "Signalling to ERK5", "PATHWAY:2001": "Defective ALG1 causes CDG-1k", "PATHWAY:2002": "Inhibition of PKR", "PATHWAY:2003": "Proline catabolism", "PATHWAY:2004": "Hydrolysis of LPE", "PATHWAY:2005": "Defective CYP26B1 causes RHFCA", "PATHWAY:2006": "Defective SLC2A9 causes hypouricemia renal 2 (RHUC2)", "PATHWAY:2007": "Tandem pore domain halothane-inhibited K+ channel (THIK)", "PATHWAY:2008": "Regulation of BACH1 activity", "PATHWAY:2009": "PTEN Loss of Function in Cancer", "PATHWAY:2010": "COX reactions", "PATHWAY:2011": "Biosynthesis of EPA-derived SPMs", "PATHWAY:2012": "Biosynthesis of DPAn-3 SPMs", "PATHWAY:2013": "PTK6 Down-Regulation", "PATHWAY:2014": "Signaling by cytosolic PDGFRA and PDGFRB fusion proteins", "PATHWAY:2015": "Activation and oligomerization of BAK protein", "PATHWAY:2016": "Defective DNA double strand break response due to BRCA1 loss of function", "PATHWAY:2017": "Defective DNA double strand break response due to BARD1 loss of function", "PATHWAY:2018": "Activation, translocation and oligomerization of BAX", "PATHWAY:2019": "SUMOylation of nuclear envelope proteins", "PATHWAY:2020": "Defective translocation of RB1 mutants to the nucleus", "PATHWAY:2021": "Retinoid metabolism disease events", "PATHWAY:2022": "Defective RHAG causes regulator type Rh-null hemolytic anemia (RHN)", "PATHWAY:2023": "Rhesus blood group biosynthesis", "PATHWAY:2024": "Defective SLC5A7 causes distal hereditary motor neuronopathy 7A (HMN7A)", "PATHWAY:2025": "Defective SLC5A7 causes distal hereditary motor neuronopathy 7A (HMN7A)", "PATHWAY:2026": "Regulation of cortical dendrite branching", "PATHWAY:2027": "Intestinal hexose absorption", "PATHWAY:2028": "Regulation of TP53 Expression", "PATHWAY:2029": "Defective ABCG8 causes GBD4 and sitosterolemia", "PATHWAY:2030": "Defective ABCG5 causes sitosterolemia", "PATHWAY:2031": "Defective pro-SFTPB causes SMDP1 and RDS", "PATHWAY:2032": "Defective pro-SFTPC causes SMDP2 and RDS", "PATHWAY:2033": "Toll Like Receptor TLR1:TLR2 Cascade", "PATHWAY:2034": "MPS IIIA - Sanfilippo syndrome A", "PATHWAY:2035": "LGK974 inhibits PORCN", "PATHWAY:2036": "Defective SLC1A1 is implicated in schizophrenia 18 (SCZD18) and dicarboxylic aminoaciduria (DCBXA)", "PATHWAY:2037": "Defective SLC1A3 causes episodic ataxia 6 (EA6)", "PATHWAY:2038": "Defective SLC2A1 causes GLUT1 deficiency syndrome 1 (GLUT1DS1)", "PATHWAY:2039": "Defective SLC2A2 causes Fanconi-Bickel syndrome (FBS)", "PATHWAY:2040": "Defective SLC7A7 causes lysinuric protein intolerance (LPI)", "PATHWAY:2041": "Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4),  distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA)", "PATHWAY:2042": "Defective SLC5A1 causes congenital glucose/galactose malabsorption (GGM)", "PATHWAY:2043": "Defective SLC5A2 causes renal glucosuria (GLYS1)", "PATHWAY:2044": "Defective SLC5A5 causes thyroid dyshormonogenesis 1 (TDH1)", "PATHWAY:2045": "Reuptake of GABA", "PATHWAY:2046": "Defective SLC6A2 causes orthostatic intolerance (OI)", "PATHWAY:2047": "Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)", "PATHWAY:2048": "Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)", "PATHWAY:2049": "Serotonin clearance from the synaptic cleft", "PATHWAY:2050": "Defective SLC12A1 causes Bartter syndrome 1 (BS1)", "PATHWAY:2051": "Defective SLC12A3 causes Gitelman syndrome (GS)", "PATHWAY:2052": "Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT)", "PATHWAY:2053": "Defective SLC34A1 causes hypophosphatemic nephrolithiasis/osteoporosis 1 (NPHLOP1)", "PATHWAY:2054": "Sodium-coupled phosphate cotransporters", "PATHWAY:2055": "Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1)", "PATHWAY:2056": "Defective SLCO2A1 causes primary, autosomal recessive hypertrophic osteoarthropathy 2 (PHOAR2)", "PATHWAY:2057": "Defective SLC22A5 causes systemic primary carnitine deficiency (CDSP)", "PATHWAY:2058": "Toxicity of botulinum toxin type E (botE)", "PATHWAY:2059": "Impaired BRCA2 translocation to the nucleus", "PATHWAY:2060": "Impaired BRCA2 binding to SEM1 (DSS1)", "PATHWAY:2061": "Toxicity of botulinum toxin type G (botG)", "PATHWAY:2062": "Defective BTD causes biotidinase deficiency", "PATHWAY:2063": "Tachykinin receptors bind tachykinins", "PATHWAY:2064": "TNF signaling", "PATHWAY:2065": "Insulin effects increased synthesis of Xylulose-5-Phosphate", "PATHWAY:2066": "TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P", "PATHWAY:2067": "TALDO1 deficiency: failed conversion of  Fru(6)P, E4P to SH7P, GA3P", "PATHWAY:2068": "Defective TBXAS1 causes GHDD", "PATHWAY:2069": "Defective TCN2 causes TCN2 deficiency", "PATHWAY:2070": "TGFBR2 MSI Frameshift Mutants in Cancer", "PATHWAY:2071": "TGFBR2 Kinase Domain Mutants in Cancer", "PATHWAY:2072": "TLR3 deficiency - HSE", "PATHWAY:2073": "UNC93B1 deficiency - HSE", "PATHWAY:2074": "Toll Like Receptor 5 (TLR5) Cascade", "PATHWAY:2075": "Loss of function of TP53 in cancer due to loss of tetramerization ability", "PATHWAY:2076": "Defective TPMT causes TPMT deficiency", "PATHWAY:2077": "Defective RIPK1-mediated regulated necrosis", "PATHWAY:2078": "Vitamin E transport", "PATHWAY:2079": "Defective SFTPA2 causes IPF", "PATHWAY:2080": "Metabolism of ingested MeSeO2H into MeSeH", "PATHWAY:2081": "The fatty acid cycling model", "PATHWAY:2083": "Defective SLC35A2 causes congenital disorder of glycosylation 2M (CDG2M)", "PATHWAY:2084": "G2/M DNA replication checkpoint", "PATHWAY:2085": "Defective MOGS causes CDG-2b", "PATHWAY:2086": "Suppression of autophagy", "PATHWAY:2087": "Defective ALG8 causes CDG-1h", "PATHWAY:2088": "Defective ALG12 causes CDG-1g", "PATHWAY:2089": "Defective SRD5A3 causes SRD5A3-CDG, KHRZ", "PATHWAY:2090": "Defective Base Excision Repair Associated with NEIL1", "PATHWAY:2091": "Mitochondrial transcription termination", "PATHWAY:2092": "Defective ALG9 causes CDG-1l", "PATHWAY:2093": "CaM pathway", "PATHWAY:2094": "XAV939 stabilizes AXIN", "PATHWAY:2095": "Invadopodia formation", "PATHWAY:2096": "ZBP1(DAI) mediated induction of type I IFNs", "PATHWAY:2097": "Defective SLC2A10 causes arterial tortuosity syndrome (ATS)", "PATHWAY:2098": "Assembly of Viral Components at the Budding Site", "PATHWAY:2099": "Synthesis of PS", "PATHWAY:2100": "Toll Like Receptor 10 (TLR10) Cascade", "PATHWAY:2101": "TWIK-related alkaline pH activated K+ channel (TALK)", "PATHWAY:2102": "TRAIL  signaling", "PATHWAY:2103": "Defective ALG2 causes CDG-1i", "PATHWAY:2104": "RUNX3 regulates RUNX1-mediated transcription", "PATHWAY:2105": "Defective ABCB11 causes PFIC2 and BRIC2", "PATHWAY:2106": "Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA)", "PATHWAY:2107": "NR1D1 (REV-ERBA) represses gene expression", "PATHWAY:2108": "Phagocyte cell death caused by cytosolic Mtb", "PATHWAY:2109": "Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes", "PATHWAY:2110": "Defective PAPSS2 causes SEMD-PA", "PATHWAY:2111": "Defective SLC6A5 causes hyperekplexia 3 (HKPX3)", "PATHWAY:2112": "Defective RFT1 causes CDG-1n", "PATHWAY:2113": "Defective SLC24A1 causes congenital stationary night blindness 1D (CSNB1D)", "PATHWAY:2114": "Defective SLC33A1 causes spastic paraplegia 42 (SPG42)", "PATHWAY:2115": "Severe congenital neutropenia type 4 (G6PC3)", "PATHWAY:2116": "Defective CYP7B1 causes SPG5A and CBAS3", "PATHWAY:2117": "Defective ACY1 causes encephalopathy", "PATHWAY:2118": "Defective MPDU1 causes CDG-1f", "PATHWAY:2119": "Synthesis of IPs in the ER lumen", "PATHWAY:2120": "Influenza Infection", "PATHWAY:2121": "Fusion of the Influenza Virion to the Host Cell Endosome", "PATHWAY:2122": "Release", "PATHWAY:2123": "Budding", "PATHWAY:2124": "Packaging of Eight RNA Segments", "PATHWAY:2125": "Uncoating of the Influenza Virion", "PATHWAY:2126": "Transport of HA trimer, NA tetramer and M2 tetramer from the endoplasmic reticulum to the Golgi Apparatus", "PATHWAY:2127": "cRNA Synthesis", "PATHWAY:2128": "Inhibition of IFN-beta", "PATHWAY:2129": "Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN)"}